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Abstract 
It is known that people can suffer from cognitive impairments following a TIA. Yet, 
currently, the methods for measuring this impairment are not very accurate or 
feasible. Whilst there is a gold standard battery to test for cognitive impairment, there 
are no up-to-date cohesive UK norms. Furthermore, current screening tools, it has 
been shown, have ceiling effects, and they are not sensitive in detecting mild 
cognitive impairments seen in a TIA profile.   
This study aims to explore whether a brief battery (BICAMS), which is used 
in MS could be an improvement on current tools. The sensitivity and specificity of the 
BICAMS were compared with a gold standard measure of cognitive impairment in 
TIA (NINDS-VCI; Hachinski et al., 2006). Furthermore, the study develops cohesive 
UK norms for the full NINDS-VCI battery to determine whether these would provide 
different outcomes to the available norm sources.  
Sixty-seven healthy UK participants were recruited to complete a 90-minute 
battery of tests – the MoCA, MMSE, BICAMS and NINDS-VCI 60-minute battery 
and a measure of estimated IQ, fatigue, anxiety and depression. Different norm 
sources were compared for the NINDS-VCI battery (published and current study). 
The numbers of participants falling below the expected level on the NINDS-VCI 
battery were compared with those identified by the three different screening tools. 
Finally, regression analyses were conducted to show which clinical and demographic 
factors contributed to performance on the NINDS-VCI and BICAMS.  
The study found that different numbers of participants fell below the expected 
levels on the NINDS-VCI battery, depending on which norm sources were used, with 
a trend towards more participants being identified with published norms. Years of 
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education was a significant predictor of NINDS-VCI scores and age was a significant 
unique contributor to BICAMS scores. BICAMS significantly correlated with 
NINDS-VCI performance and was found to be more sensitive and specific than the 
MoCA or MMSE.  
Relevant and up-to date cohesive norms are important to evaluate performance 
accurately on the NINDS-VCI –VCI 60-minute battery. BICAMS shows promise as a 
suitable screening tool to measure mild cognitive impairment after a TIA. Further 
research should focus on comparing TIA participants with UK matched controls.   
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This introduction reviews the literature pertaining to the current study. It begins by 
describing the National Institute of Neurological Disorders and Stroke-Canadian 
Stroke and Vascular Cognitive Impairment Harmonisation Standards 60-minute 
neuropsychological test battery, and the importance of neuropsychological testing in 
TIA and mild stroke. It examines the importance of providing up-to-date normative 
data for comparison with clinical groups, before exploring the prevalence, risk factors 
and neuropsychological profile of TIA and mild stroke. Furthermore, the current 
challenges in detecting cognitive impairment and the available screening tools are 
considered. The rationale and outline of the study are also provided.  
1.1 Recommended Neuropsychological Testing in Stroke and TIA  
1.1.1 Overview 
This section details the current recommendations for neuropsychological testing in 
Vascular Cognitive Impairment (VCI). It describes what research has been carried out 
using this battery and the available normative data. It refers to the importance of 
cohesive and current norms for understanding neuropsychological testing.  
1.1.2 The National Institute of Neurological Disorders and Stroke-Canadian Stroke 
and Vascular Cognitive Impairment Harmonisation Standards (NINDS-VCI). 
In 2006, The National Institute of Neurological Disorders and Stroke (NINDS) and 
Canadian Stroke Network (CSN) together developed a set of data elements that they 
recommended for use in all future studies of VCI (Hachinski et al., 2006). The aim 
was to achieve a more comprehensive understanding of VCI. Recommendations for 
examining cognition were developed. This included a 60-minute, 30-minute and 5-
minute neuropsychological test battery. The 60-minute battery is the gold standard 
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assessment battery, the 30-minute battery is a subset of key tests within the 60-minute 
battery and the 5-minute battery is the Montreal Cognitive Assessment (MoCA). The 
60-minute battery aims to cover deficits across all cognitive domains, with particular 
emphasis on measuring executive function, information processing speed and working 
memory, which are considered to be key cognitive deficits in VCI. The working 
group highlighted the importance of ensuring tests were sensitive to a range of 
abilities. The protocol includes the following tests: Trail Making Test (Parts A and B) 
(TMT; Reitan, 1955), Boston Naming Test (BNT; Mack, Freed, Williams, & 
Henderson, 1992), Rey-Osterrieth Complex Figure Copy (ROCFT; Fastenau, 
Denburg, & Hufford, 1999), Hopkins Verbal Learning Test-Revised (HVLT-R; 
Benedict, Schretlen, Groninger, & Brandt, 1998; Brandt, 1991), Letter Fluency 
(Controlled Oral Word Association Test) (COWAT; Benton, Hamsher, & Sivan, 
1994) and Category (animals) Fluency (Issacs & Kennie, 1973).   
The battery was chosen by expert opinion based on current knowledge on VCI 
and its related cognitive deficits. Since its development, the battery has been utilised 
in a number of countries, including France (Godefroy et al., 2011), Canada (Mandzia 
et al., 2016), the United States (Han, Anderson, Jones, Hermann, & Sattin, 2014; 
Wang et al., 2016), Korea (Yu et al., 2013), Taiwan (Lin et al., 2016), Hong Kong 
(Wong et al., 2012), Singapore (Xu et al., 2016) and China (Chen et al., 2015). 
National databases have been devised and are now in place to collect the outcomes of 
studies using the battery (Stroke Standards - NINDS Common Data Elements). 
Furthermore, the battery has been used in research to show that performance on each 
of the cognitive domains is associated with volumetric brain changes (Wang et al., 
2015; Wong et al., 2015). The battery also discriminates between different diagnoses, 
such as mild cognitive impairment and dementia in memory clinics (Xu et al., 2016). 
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In the United States the battery has been incorporated into stroke patient care 
demonstrating good clinical feasibility, and providing an efficient method for the 
provision of focused neuropsychological assessment (Han et al., 2014).  
Many of the studies using the battery have focused on TIA and mild stroke. 
Their findings have highlighted the prevalence of cognitive impairment in TIA, 
described the neuropsychological profile of deficits and tested potential screening 
tools, to examine if they can accurately detect impairments to the same degree as the 
60-minute NINDS-VCI battery. Currently, no guidelines exist for the assessment or 
treatment of cognitive impairment in TIA in the UK (NICE, 2008). Only recently has 
it been acknowledged that cognitive deficits are present and persist past the acute 
phase of the TIA. As research develops, the case will be made for further assessment 
and treatment for cognitive deficits in this clinical group.  
Furthermore, understanding of VCI, particularly in TIA, appears to be a 
growing area of research internationally. There is currently a large multi-centre 
national trial taking place in France to validate a French version of the NINDS-VCI, 
although the results are not yet available (ClinicalTrials.gov ID: NCT01339195). The 
value of developing a neuropsychological test battery to use internationally is that 
research can develop a clearer picture of the cognitive deficits at the acute phase, sub- 
acute phase and the chronic phase of stroke and TIA. The systematic application of 
assessment will improve the ability to evaluate the risk of cardiovascular procedures 
and safety effectiveness of preventative therapies (Lansky et al., 2017). This will 
increase knowledge of the disease and, in turn, inform treatment. 
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1.1.3 Current Norms and the Importance of Cohesive Norms 
Despite the NINDS-VCI test battery being validated in a number of countries, and the 
recognition of its importance in advancing knowledge of VCI, no validation of the 
battery has taken place in a UK population. Notable UK investigations of TIA 
cognition have relied on several historical normative datasets from manuals and other 
sources, spanning several decades and from other countries (Pendlebury, Mariz, Bull, 
Mehta, & Rothwell, 2012, 2013). The normative comparisons that are currently in use 
to evaluate performance on the NINDS-VCI in the UK span from 1982 to 1999 
(Benedict et al., 1998; Fastenau et al., 1999; Ivnik, Malec, Smith, Tangalos, & 
Petersen, 1996; Smith, 1982). These norms are also from different parts of the United 
States (Minnesota, Baltimore, Indiana and Los Angeles), which calls into question 
their relevance to a UK population. These are derived from a range of standardisation 
sources recommended by Hackinski et al. (2006) (cf. Crossley, D’Arcy, & Rawson, 
1997; Goodglass et al., 2001; Gorp, Satz, & Mitrushina, 1990; Heaton, 2004; Ivnik et 
al., 1996; Kozora & Cullum, 1995; Ruff, Light, Parker, & Levin, 1996; Selnes et al., 
1991; Tombaugh & Hubley, 1997; Wechsler, 1997).  
Recency has been argued as the most important factor when considering 
which normative data to use. This is due to the Flynn effect: mean average scores are 
likely to change by three to nine points per decade. The Flynn Effect, furthermore, has 
additional sources of complexity when different tests are used to create a battery. This 
is because different tests within the battery are normed in different decades. Batteries 
that provide co-normed subtests in a variety of neuropsychological domains are 
thought to provide a clear advantage over test combinations (Strauss, Sherman, & 
Spreen, 2006). Therefore, the lack of current and cohesive datasets for cognitive 
evaluation in TIA not only weakens experimental investigations of prevalence and 
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outcome, but also means that individual clinical assessments of cognition lack current, 
cohesive norms. 
Whilst some of the studies have relied on published norms to compare 
experimental data (Mandzia et al., 2016; Pendlebury et al., 2012), others have used a 
current comparison of participants from the same population. For example, Chen et al. 
(2015) compared 50 mild stroke participants with 50 stroke free participants. Group 
comparisons were then made through t-tests by using a summary z-score for each 
cognitive domain and comparing z-scores between the two groups. The same 
approach has been used to validate the battery in Hong Kong (Wong et al., 2012) and 
Taiwan (Lin et al., 2016). 
Traditional norming relies on discrete norms, which provide sets of 
descriptives for a specific age band. Norms can sometimes be based on rather 
arbitrary age bands. This can mean that a person’s performance can vary depending 
on which age band he or she falls into. For example, Zachary and Gorsuch (1985) 
noted that a person’s IQ score on the Wechsler Adult Intelligence Scale–Revised 
(WAIS-R) could increase up to six points by ageing a single day when the raw test 
scores pass from comparison with the 25–34 to the 35–44 year age group. 
Furthermore, large samples are required to ensure reliability. Generally 20 to 30 
participants are required per stratification band, which means that over 300 
participants would be required for five age and education bands, before any other 
variables are considered (Testa, Winicki, Pearlson, Gordon, & Schretlen, 2009). 
Conversely, continuous norms can be calculated using a regression model. 
Regression-based norms (RBN) can be extremely useful in providing information that 
is tailored to the individual’s attributes, such as age, gender, IQ, educational level and 
socioeconomic status. The demographic factors can be used in a multiple regression 
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to predict test performance based on the participant’s demographic characteristics. 
RBN also makes it possible to account for non-linear effects such as age. Compared 
with traditional norming, regression-based norming requires a smaller sample to 
obtain equally precise norms, as they depend primarily on the assumptions of multiple 
regression being met (Bechger, Hemker, & Maris, 2009). The statistical advances in 
creating norms that account for a wider variety of clinical and demographic factors 
would facilitate the interpretation of outcomes on the NINDS-VCI 60-minute battery 
in a UK population.   
1.1.4 Summary 
The NINDS and CSN have recommended a 60-minute gold standard test battery, 
which is being used internationally to advance knowledge of VCI. The battery has 
proved particularly useful in developing knowledge of mild stroke and TIA. However, 
recent UK studies have used normative data from the United States dating back to the 
early 1980s to diagnose cognitive impairments. This is likely to be inaccurate and 
cause misclassification and faulty identification of cognitive impairment. A normative 
data set using regression-based norms on UK participants across all tests of the 
NINDS-VCI battery will further enhance our understanding of cognitive impairment 
in TIA and stroke.  
1.2 TIA and Mild Stroke Synopsis  
1.2.1 Overview 
This section describes the current prevalence of TIA and mild stroke, as well as the 
prevalence of VCI, before discussing the impact on daily life. It also considers how 
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cognitive testing could facilitate our understanding and targeted treatment of people 
who experience difficulties after a TIA or mild stroke.  
1.2.2 Epidemiology of TIA 
A TIA is commonly known as a mini stroke. Physical symptoms include 
weakness of the face, arm or leg that is particularly one sided, diplopia (double 
vision), monocular visual loss, dysarthria (unclear articulation of speech), aphasia and 
loss of balance or co-ordination. Cognitive signs include disorientation and problems 
with comprehension and verbalisation. Physical symptoms are known to resolve 
usually within an hour. It is estimated that 54,000 TIAs occur every year in the UK 
(Giles & Rothwell, 2007), with an incidence rate of 0.66 in 1000 (0.45 in 1000 for 
men and 0.89 in 1000 for women).  
A stroke is defined as rapidly developing clinical symptoms and or signs of 
focal and at times global loss of brain function, with symptoms lasting more than 24-
hours or leading to death, with no apparent cause other than that of vascular origin 
(Hatano 1976). There are two competing definitions of TIA. Depending on which one 
is used, this can change the prevalence rates of both stroke and TIA significantly. The 
original definition is of “an acute loss of focal brain or monocular function, with 
symptoms lasting less than 24-hours, which is thought to be caused by inadequate 
cerebral or ocular blood supply as a result of arterial thrombosis, low flow or 
embolism associated with arterial, cardiac or haematological disease” (Hatano, 1976). 
This definition does not require the use of imaging for diagnosis and is based on 
observation of clinical symptoms. An alternative and more recent definition has been 
proposed: “a transient episode of neurologic dysfunction caused by focal brain, spinal 
chord or retinal ischemia, without acute infarction” (Albers et al., 2002; Easton et al., 
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2009). Advances in neuroimaging, particularly diffusion-weight MRI, show that 30–
50% of those classically defined as having a TIA have small acute lesions (Brazzelli 
et al., 2014; Easton et al., 2009; Moreau, Jeerakathil, & Coutts, 2012). Using the later 
definition would mean that these patients are diagnosed with a stroke rather than a 
TIA. This has implications for access to assessment and treatment for stroke that is 
not currently available for TIA. Generally, in clinical practice, brain imaging, which is 
sensitive to identifying such small changes, is not routinely available and diagnosis is 
instead usually based on clinical history (NICE, 2008). This means that the first 
definition, which is time-based is usually favoured and used in clinical practice. This 
results in a higher rate of TIA diagnosis and a lower rate of stroke diagnosis.  
There is a lack of clarity and considerable overlap in the literature between 
definitions of TIA, minor stroke and stroke, with at least six different definitions of 
minor stroke (Fischer et al., 2010). Studies often include and report findings for more 
than one group, and they may lack clear guidance on the definitions used to classify 
participants. However, the cognitive profile seen in a TIA mirrors the profile in a 
stroke: the same deficits are present, although in a stroke, they are likely to be more 
severe and across more than one domain (Sachdev et al., 2004). The cognitive profiles 
of stroke and TIA are known to be vascular in nature and match the VCI profile 
(Nyenhuis & Gorelick, 2007; Sachdev et al., 2004). This means that despite the 
overlap in studies reporting TIA and stroke together, they still can provide valuable 
information about VCI in TIA. Therefore, it is considered more appropriate to include 
stroke and TIA as part of a continuum of VCI rather than separate entities. This 
review of the literature explores both minor stroke and TIA studies.  
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Studies examining the factors that are likely to increase the occurrence of a 
TIA have been carried out. A recent study by Ström, Tavosian, and Appelros (2016) 
compared characteristics of TIA patients with the general population and found that 
the former were more likely to have diabetes, atrial fibrillation and to smoke. It was 
less likely for the TIA population to be taking blood pressure medication, suggesting a 
higher proportion of untreated hypertension, which may be a contributing factor.  This 
confirms previous studies’ findings (Dennis, Bamford, Sandercock, & Warlow, 1989; 
Whisnant et al., 1999), that diabetes and current smoking increased the odds ratio for 
TIA by 1.5 each and atrial fibrillation by a factor of 5. 
The focus of treatment after a TIA is to reduce the risk of stroke and further TIAs. 
The risk of stroke following TIA is high: 5% at two days, 8% at seven days, 7–12% at 
30 days (Lavallée & Amarenco, 2014). This emphasises the importance of immediate 
medical treatment. The EXPRESS study indicated that early intervention in TIA could 
reduce the 90-day risk of recurrent stroke by 80% (Rothwell, Algra, & Amarenco, 
2011). Various risk stratification formulas have been developed and validated to help 
target those most at risk of a further vascular event. The ABC!! is the current risk 
stratification formula recommended in the guidelines of the National Institute of 
Clinical Excellence (NICE, 2008). The ABCD! score is a risk assessment tool 
designed to improve the prediction of short-term stroke risk after a transient ischemic 
attack (TIA). The score is optimized to predict the risk of stroke within 2 days after a 
TIA, but also predicts stroke risk within 90 days. The ABCD!  score is calculated by 
summing up points for five independent factors: age, blood pressure, clinical features 
(unilateral weakness and or speech impairment), duration and diabetes.  There have 
been several attempts to enhance this risk stratification process by adding imaging 
results (Giles et al., 2011) or etiological considerations, though it is recognised that 
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this would require an extensive diagnosis work up (Wolf, Held, & Hennerici, 2014). 
However, accurate cognitive screening has the potential to enhance the risk 
stratification process and predict more reliably who is most at risk of further vascular 
events. For example, a study with elderly participants showed scores on the MMSE to 
be a better predictor of stroke than Framingham Vascular Risk Scores (Sabayan, 
Gussekloo, Ruijter, Westendorp, & Craen, 2013). Cognitive status is likely to be a 
useful predictor or an additional source of information for understanding future risk of 
vascular events. Identifying accurate screening tools that are cost and time effective 
could add to our understanding and prevent further vascular events and vascular 
dementia (VaD). 
 
1.2.3 Prevalence of Cognitive Impairments after TIA 
Rates of cognitive impairment in TIA vary across studies. A recent systematic review 
found rates of mild cognitive impairment between 29 and 68%, with severe cognitive 
impairment (impairment in two or more domains) in 8–22% of patients (van Rooij, 
Kessels, Richard, De Leeuw, & van Dijk, 2016). Another systematic review in 2014 
found rates of cognitive impairment between 17 and 54% (Moran et al., 2014).  
Studies have examined the profile of cognitive impairments following a TIA. 
Van Rooij et al. (2014) tested 114 participants aged 45–65, without history of stroke 
or dementia to 81 controls, three months after TIA. They used CT and MRI imaging 
to establish the presence of infarction or white matter disease. They found that over 
one third of the participants experienced cognitive impairment in at least one domain. 
The most commonly impaired cognitive domains were working memory, information 
processing and attention. They found global memory was most likely to remain intact. 
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Subjective complaints were higher in the TIA participants than controls. Imaging 
studies showed that 59% had brain infarcts, and these participants were much more 
likely to experience cognitive impairment.   
Similarly, Pendlebury et al. (2012) tested 91 participants with TIA or minor 
stroke one year later on a full neuropsychological battery of tests. They found that 
42% experienced cognitive impairment, with the majority being in visuospatial, 
executive and attentional tasks. Memory and language were more likely to be 
preserved.   
Sachdev et al. (2004) compared 170 participants with mild stroke or TIA to 96 
aged matched controls on a detailed neuropsychological battery. They showed that 
nearly 60% experienced cognitive impairment in one or more domains. Impairment in 
abstraction, mental flexibility, information processing speed and working memory 
were the most common deficits.   
These studies support the theory that the cognitive impairment seen in TIA has 
a vascular profile, characterised by attention, information processing and executive 
function deficits, with relatively intact memory function. However, studies do vary in 
terms of the specific cognitive domains that are impaired and the percentage of people 
identified with cognitive impairments. This is likely to be due to different 
measurement tools and definitions.  
The use of a screening tool to identify impairments would be valuable, 
followed by a full neuropsychological battery to conceptualise the precise profile of 
TIA related cognitive impairment.   
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1.2.4 The Impact of Cognitive Impairments after TIA on Daily Life  
Separating the impact of cognitive deficits on daily life from other factors is a 
challenge, as depression, anxiety and fatigue are also known to correlate with quality 
of life following TIA (Coutts et al., 2012; Moran et al., 2014). Many people continue 
to self-report negative consequences of TIA many years later. In a qualitative study, 
participants reported experiencing physical, practical and psychological consequences 
following a TIA (Croot et al., 2014).   
A study by Coutts et al. (2012) found that 90 days after a TIA, 15% of 
participants were classified as disabled, according to the modified Rankin Scale 
(mRS), with a score of ≥2. The authors suggest that disability could be due to 
cognitive impairment, although this cannot be determined through the mRS measure. 
A similar level of disability was found in another self-report study, which did include 
a measure of cognitive functioning. At 90 days, 12% of participants were classified as 
disabled. They reported impairments in social roles and activities, applied cognition, 
including executive function, and general cognition, including memory, attention and 
decision-making (Sangha et al., 2015).  
Kjörk, Blomstrand, Carlsson, Lundgren-Nilsson and Gustafsson (2015) found 
that self-reported problems persist at nine months and may also increase. Thirty-two 
percent of a TIA cohort still reported problems in daily life nine months later. 
Communication problems increased from 16% at three months to 33% at nine 
months. This gives further evidence of long-term self-reported difficulties after a TIA.  
People working outside the home are more likely to report difficulties (Muus, 
Petzold, & Ringsberg, 2010). One hundred and five participants with mild stroke or 
TIA completed the Stroke Specific Quality of Life Scale: 13% with a TIA reported a 
decrease in quality of life one year later. Those reporting a decrease in quality of life 
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were more likely to be in employment. This change, it has been proposed, results 
from the higher cognitive demands placed on them at work; such subtle difficulties 
may go undetected in other, less cognitively-demanding settings. The study also 
found that being male was more likely to predict a reduction in quality of life one year 
later. This contradicts the findings of another recent longitudinal cohort study of 619 
first ever stroke and TIA participants, aged between 18 and 50 years old. They noted 
that 14 years later, 1 out of 10 individuals are still dependent in daily life, with a two 
to threefold higher risk of a poor outcome in women. The authors proposed that this 
may be due to less social support for young women than men after stroke (Franzén-
Dahlin & Laska, 2012).  
Quality of life appears to be negatively affected for a significant number of 
people following a TIA. Some studies have found this to be linked to cognitive 
impairment, although no direct correlational studies have been conducted. Studies are 
mainly self-report, which may bias findings. However, there are clear negative effects 
on daily life after experiencing a TIA. Assessment of cognition following a TIA 
would identify those most likely to have difficulties in returning to their day-to-day 
activities. Being able to provide cognitive rehabilitation and further support for this 
population would likely increase quality of life and wellbeing following mild stroke 
and TIA.  
1.2.5 Treatment of TIA in UK NHS   
Dementia affects 5–7% of people over the age of 60. Cerebrovascular disease, such as 
TIA, have been shown to increase significantly the likelihood of experiencing VaD, 
with the risk increasing for those who experience multiple vascular events (Gorelick 
et al., 2011; Gorelick, Counts, & Nyenhuis, 2016). Therefore, treatment following a 
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TIA focuses on medications to reduce the risk factors that are known to increase the 
possibility of another TIA or other vascular event. Medication is used to reduce 
hypertension, hyperlipidaemia and atrial fibrillation. A surgical intervention, Carotid 
Endarterectomy, is used to unblock the main blood vessels that supply the neck and 
head when there is a narrowing of the carotid artery.   
Although medication and surgery are shown to prevent further vascular 
events, neither has a significant impact on VCI (Pettigrew, Thomas, Howard, 
Veltkamp, & Toole, 2000; Ritter & Pillai, 2015). VCI following a TIA is known to 
have an impact on quality of life (Coutts et al., 2012; Moran et al., 2014). 
Nevertheless, NICE guidelines currently do not include cognitive testing or 
rehabilitation as part of the treatment. Cognitive testing could be a valuable addition 
to treatment to understand those who are experiencing cognitive impairments after a 
TIA. This would allow treatment resources to be directed towards those who are more 
impaired from a TIA, thus focusing on improving their quality of life. Clinicians 
would also be provided with valuable information about those who may be more at 
risk of future vascular events to help target medical and surgical treatments.  
1.2.6 The Case for Cognitive Screening 
Studies have shown that cognitive impairment at the acute phase can predict long-
term cognitive impairment and prognosis. For example, Dong et al. (2012) found that 
scores on a cognitive screen in the acute stage predict outcomes one year later. This 
finding has been corroborated by Kliper et al. (2015), who correlated 
neuropsychological test scores and neuroimaging results across the acute phase, six 
and 12 months, and found that tests in the acute phase predicted outcomes on 
cognitive testing at a 12-month follow-up. Studies have also shown that cognitive 
 27 
impairment in the acute phase can predict risk of stroke and VaD (Dong et al., 2013; 
Pettigrew et al., 2000). This highlights the important role of assessing for cognitive 
impairment following TIA, in order to target treatment for those most at risk of 
further vascular events and cognitive impairments.   
However, it is acknowledged that a 60-minute gold standard battery is unlikely 
to be feasible in TIA clinics, due to limitations on resources. However, a screening 
tool could be used to identify those who are experiencing cognitive impairments. This 
would then mean that only those who have been identified as experiencing cognitive 
deficits undergo a full 60-minute assessment. The screening process is popular in 
other parts of the health system and has been used effectively in multiple sclerosis 
(MS) (Dusankova, Kalincik, Havrdova, & Benedict, 2012; O’Connell, Tuokko, 
Graves, & Kadlec, 2004). Screening tools usually require minimal training and can be 
delivered by a range of healthcare professionals negating the need for expensive 
specialists to assess each patient. Screening for cognitive impairment is likely to be a 
time efficient way to highlight those most in need of treatment and further 
intervention. Although screening tools, such as the Mini-Mental State Examination 
(MMSE) and Montreal Cognitive Assessment (MoCA), have been proposed and 
utilised in TIA and mild stroke, they have been shown to have ceiling effects that 
inhibit the detection of subtle cognitive impairments, which are likely to be seen 
following a TIA. Further exploration of tools that can improve on the MMSE and the 
MoCA are necessary.  
1.2.7 Summary 
TIA is a common vascular event; there are known risk factors that increase the 
likelihood of experiencing a TIA, including diabetes, atrial fibrillation and smoking. 
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Cognitive deficits after a TIA are also prevalent and appear to impact peoples 
everyday life years later. Yet, currently, there is no screening for cognitive 
impairment following a TIA and thus no treatment available. If cognitive testing was 
introduced, this could help identify those most at risk of experiencing such negative 
impacts on their daily life, and those most likely to go on to have further vascular 
events and possible VaD. Identifying those most at risk would help target treatment 
and prevention strategies more effectively and thus reduce the impact on peoples 
quality of life and reduce the prevalence of VaD.   
1.3 The Neuropsychological Profile of TIA and Mild Stroke 
1.3.1 Overview 
This section describes the current research findings on cognition across different 
functional areas including processing speed, executive function, language, learning 
and memory and visuospatial abilities.  
1.3.2 Processing Speed 
Information processing speed is a measure of how quickly information can be taken in 
and, subsequently, made sense of. TIA and stroke studies have shown slowed 
information processing speed to be impaired compared with controls. Participants 
with TIA and stroke produce significantly slower response times than matched 
controls on a number of well-known tests of information processing speed, including 
TMT-A (Chan et al., 2014; Mandzia et al., 2016; Sachdev et al., 2004; Sörös, 
Harnadek, Blake, Hachinski, & Chan, 2015), Symbol Digit Modalities Test (SDMT) 
(Chan et al., 2014; Pendlebury et al., 2012; Sachdev et al., 2004), WAIS Symbol Digit 
Coding (Chen et al., 2015; Mandzia et al., 2016), Reaction time tasks (Bakker et al., 
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2003; Gerritsen, Berg, Deelman, Visser-Keizer, & Jong, 2003) and Stroop and 
Concept Shifting Tasks (Rasquin et al., 2004). Furthermore, stroke studies have found 
that the more complex the decision to be made, the slower the speed of processing 
compared with controls (Gerritsen et al., 2003). A recent study in a Chinese 
population looked at WAIS Symbol Digit coding as a screening measure of VCI in a 
mild stroke cohort and identified a sensitivity of 75% and specificity of 61% (Lin et 
al., 2016). Dong et al., 2014 also found the SDMT to be equivalent to the MoCA and 
MMSE in detecting mild cognitive impairment, although it was not sensitive to 
detecting those with amnestic cognitive impairment, which was 10% in their study.  
Stroke studies have also shown processing speed to have a mediating 
relationship with other cognitive domains (Su, Wuang, Lin, & Su, 2015). Processing 
speed mediated the impairments across other cognitive domains. Therefore, 
processing speed is the cognitive function that is affected in terms of severity and 
prevalence, and also underlies post stroke cognitive dysfunction.  
Tham et al. (2002) tested 252 stroke and TIA participants using the SDMT and 
Digit Cancellation and found scores predicted cognitive decline one year later. 
Furthermore, a stroke study also found processing speed to be a significant 
independent predictor of disability and health related quality of life five years after 
stroke. The contribution of processing speed was a better predictor than age, 
depression and stroke severity (Barker-Collo, Feigin, Parag, Lawes, & Senior, 2010). 
This was supported by another study, which found that processing speed 
independently predicted dependency after stroke and TIA (Narasimhalu et al., 2011).  
Processing speed appears to be a key cognitive deficit demonstrated across 
multiple studies of stroke and TIA. Research has shown that processing speed 
mediates the relationship between other cognitive domains and is predictive of quality 
 30 
of life and dependency. Therefore, a measure of information processing speed would 
be extremely useful in a brief cognitive test to indicate whether cognitive impairment 
may be present in TIA patients.  
1.3.3 Learning and Memory  
Memory deficits have typically been associated with dementia and Alzheimer’s, 
rather than the CVD pathology in TIA (Gorelick et al., 2016). However, the ability to 
learn and recall new information has been shown to be reduced in some people with 
TIA. A large population based study found that 7% of people who had experienced a 
TIA also experienced a memory impairment (Takahashi et al., 2009). Verbal word 
learning list tasks such as the California Verbal Learning Test (CVLT-II) and Hopkins 
Verbal Learning Test Revised (HVLT-R) have shown significant differences between 
TIA participants and controls (Chen et al., 2015; Levine et al., 2015; Pendlebury et 
al., 2012; Wong et al., 2015). A recent study found that 20% of a TIA cohort were 
impaired on memory domain as measured by CVLT-II and Rey Memory Trial 
(Mandzia et al., 2016).  
However, other studies have differing results; for example, van Rooij et al. 
(2014) compared TIA participants with controls and identified no significant 
difference in rates of episodic memory impairment compared with controls. Sachdev 
et al. (2004) also found impairments in all other domains except verbal memory. 
According to Pendlebury et al. (2013), TIA participants were less likely to have 
impairment in memory than other cognitive domains. However, those who did have 
an impairment in memory, also had an impairment in another cognitive domain, and 
this group showed more impaired long-term outcomes compared with those who were 
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only impaired in one domain. This suggests that memory could be a key indicator of 
more severe impairment and cognitive impairments in the long term.  
Tests of visual learning and memory including delayed recall of the ROCFT, 
Visual Reproduction in Wechsler Memory Scale (WMS) (Chen et al., 2015; Sachdev 
et al., 2004) and Recognition Memory Test and Doors and People Test (Chan et al., 
2014), have been shown to be impaired in TIA participants (Chen et al., 2015; 
Sachdev et al., 2004), whilst other studies have shown visual memory to remain intact 
(Pendlebury et al., 2012).   
Tham et al. (2002) found scores on both verbal memory and visual memory 
predicted those most likely to deteriorate in cognition, compared with those who were 
more likely to improve or remain stable. Neuroimaging studies have correlated early 
changes in the hippocampus with memory impairment, which continues to be present 
up to 10 years after TIA and stroke (Kliper et al., 2015; Schaapsmeerders et al., 2015).  
The mixed profile demonstrated across studies may be linked to the 
heterogeneous profile of participants and study design. Tests may not be sensitive to 
the mild deficits seen in a TIA cohort (Gorelick et al., 2016). Certainly, tests of 
memory in current screening tools such as the MoCA and MMSE involve the 
participant remembering three words. This is often unchallenging and errors are 
usually due to attention or encoding problems, rather than deficits in learning and 
memory specifically. 
In summary, not all studies have shown that impairments in memory occur in 
a mild stroke or TIA population. These findings may be due to a number of reasons 
linked to the research design or selection of participants. However, some studies have 
revealed that impairments in verbal and visual memory tasks are predictive of future 
outcomes and indicate more severe impairments in cognition. This highlights the need 
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for further exploration of memory in TIA and mild stroke patients to determine 
whether a sensitive measure of memory could be useful in identifying those most at 
risk of further cognitive impairment, vascular events or VaD.  
1.3.4 Executive Function  
Executive functions are a heterogeneous group of skills required for effective 
planning and execution of goal-orientated behaviour. Executive functions include 
working memory, abstraction, reasoning, verbal fluency and cognitive flexibility 
(Takahashi et al., 2007). Even mild impairments in executive function may impact an 
individual’s ability to plan, initiate and execute behaviours involved in activities of 
daily living such as managing medication and finances.       
The broader literature on VCI shows that executive function is one of the key 
impairments present even in the very early stages of CVD (Nyenhuis & Gorelick, 
2007; Sachdev et al., 2004). Yet, the profile is still variable across different studies 
and across different aspects of executive functioning. For example, Sörös et al. (2015) 
found that 57% of their sample were impaired in their executive functioning abilities 
as measured by TMT. Over one third of participants were classified as impaired on 
TMT-A and 40% were classified as impaired on TMT-B.  Lower, but still significant, 
rates of impairment in executive functioning have been reported in other studies using 
TMT. Pendlebury et al. (2012) found impairments of 16% and 7%, respectively, for 
Parts A and B of the TMT, whilst Sachdev et al. (2004) identified a significant 
difference in TMT B compared with controls, but did not find a significant difference 
in TMT-A. Chen et al. (2015) also noted significant differences compared with 
controls on TMT, although they found a larger effect for TMT-A than TMT-B.    
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Verbal fluency tests have also shown differing results; significant differences 
have been found across studies of TIA and stroke patients compared with controls on 
semantic naming tasks (Bakker et al., 2003; Chen et al., 2015; Sachdev et al., 2004). 
Furthermore, Pendlebury et al. (2012) highlighted minor impairments compared with 
controls on animal and letter fluency tests (2% each). Van Rooij et al. (2014) reported 
10% of the sample was impaired on either verbal fluency or the Stroop Interference 
Task compared with controls.  
Impairments have been reported in executive functioning across studies. Yet, 
impairments seen in the executive functioning domain may be attributable to slowed 
information processing speed as both the TMT and tests of fluency are timed tasks 
that require the participant to be able to process information quickly to perform well.   
1.3.5 Language  
Language can be conceptualised as expressive and receptive language functions.  
Disruptions to language skills are associated with grey matter atrophy, which is not 
usually seen in TIA patients, but is evident on the severe end of VCI continuum. 
Gorelick et al. (2016) highlighted that the current test of language function in the 
NINDS-VCI battery may not be as sensitive in this population as the test for executive 
function and memory, and so may not show deficits even if they are present. The 
current suggested test is the BNT (Franzén-Dahlin & Laska, 2012). Participants are 
presented with line drawings of common objects and animals and asked to name 
them. The argument is that using similar naming tasks in screening tools may not 
identify language deficits in this cohort. This, moreover, may artificially inflate their 
overall scores, as naming is likely to be insensitive to the level of change found in 
TIA patients’ cognitive abilities.  
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Nonetheless, impairment in language has been identified in some studies. 
Pendlebury et al. (2012) found that 2% of the TIA cohort were impaired on the BNT. 
Chen et al. (2015) also revealed a significant difference in scores on the BNT between 
mild stroke participants and controls. However, most studies have not found 
impairments in the language domain (Mandzia et al., 2016; Sachdev et al., 2004). 
Generally, across studies, rate of impairments appears to be low and may be due to 
variations in inclusion criteria or the insensitivity of language tools used.  
1.3.6 Visuospatial Deficits  
Visuospatial construction encompasses recognition of visual stimuli and accurate 
perception of their characteristics. Deficits in visuospatial skills have been found in 
studies using the ROCFT (Chen et al., 2015; Pendlebury et al., 2012), the Block 
Design Task (Sachdev et al. 2004) and clock drawing task (Sörös et al., 2015). A 
recent study found that clock drawing and cube drawing significantly detected 
cognitive impairment in a stroke and TIA sample (Mai, Sposato, Rothwell, Hachinski, 
& Pendlebury, 2016). Furthermore, Tham et al. (2002) found WMS-R and Block 
Design Test to predict patients who were more likely to decline in cognitive 
functioning over a one-year period compared with those who were more likely to 
remain stable or improve. A visuospatial test may be a useful component to include in 
a screening test, which is more sensitive to mild impairments.  
1.3.7 Summary 
Research into the cognitive domains in TIA has shown a mixture of findings. 
Impairments have been seen across all cognitive domains, although not all studies 
concur with regards to which areas the deficits are observed in, other than executive 
functioning and information processing speed. This may be due to the heterogeneity 
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of studies and the different ways in which impairment is measured. However, it is also 
possible that impairments in TIA are global rather than focal. It is hypothesised that 
certain brain areas are central to the impairments caused by vascular disease and other 
brain areas that when disrupted overlay on the central dysfunction (Cumming, 
Marshall, & Lazar, 2013; Sachdev et al., 2004; Su et al., 2015), causing global 
deficits. Therefore, a test of cognition that can account for small changes in 
performance across skills that recruit multiple domains may be more helpful than 
assessing numerous individual cognitive domains at a low level.   
1.4 Challenges in Detecting Cognitive Impairment in TIA  
1.4.1 Overview  
This section describes some of the challenges in understanding cognitive 
impairments, as well as the factors that influence cognitive testing, including mood, 
fatigue and anxiety.  
1.4.2 Heterogeneity of Studies  
No meta-analysis has been possible across TIA studies due to heterogeneity. The 
difference between studies occurs at each stage of the research process.  
1.4.2.1 Inclusion Criteria  
The age of participants included across studies varies. For example, van Rooij et al. 
(2014) included participants under the age of 65, whilst all those in the group of 
Pendlebury et al. (2013) were over the age of 60. The use of older participants is 
likely to influence cognitive functioning due to other age-related white matter changes 
(Ferro & Madureira, 2002). Not all studies have excluded existing dementia or 
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previous stroke, which is also likely to impact rates of impairment and skew 
prevalence rates of cognitive impairment.  
Participants also have different diagnoses. Studies often combine mild stroke 
and TIA to report findings, which may mean that cognitive impairments are inflated 
compared with studies where only TIA participants are included. For example, a study 
by Shopin et al. (2013) compared stroke with TIA patients across global cognitive 
function, memory, visuospatial, verbal and attention and found that stroke patients 
had significantly more impairments across all domains than TIA patients. Time-based 
and tissue-based definitions have been used varyingly across studies; this is also likely 
to lead to different reported rates of impairment.  
Few studies test participants immediately after their TIA. There is usually a 
delay of three months to one year. Participants within a study may have been tested at 
differing times since their TIA. Rates of impairment are known to be higher 
immediately after a TIA (Salvadori et al., 2013), which needs to be accounted for in 
comparisons.  
1.4.2.2 Measuring Cognition  
Screening tools are widely used in this cohort to measure cognition. Suggested cut-
offs vary between the studies, and this can often vary depending on the testing period 
(acute, sub-acute, chronic). The MMSE has been widely criticised as a screening tool 
for VCI, yet, it continues to be used as an outcome tool. This is likely to have 
implications for research findings and future directions for research (Webb et al., 
2014).   
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1.4.2.3 Defining Impairment  
Some studies have collected data on matched controls to compare outcomes of TIA 
participants. Impairment on a test or within a domain is generally established by using 
t-test to determine whether there is a significant difference between the groups on 
scores. Other studies have relied on published normative data sets.  
Furthermore, there is no clear consensus on the definition of cognitive 
impairment. There are at least 18 different definitions and terms in use (Pendlebury, 
Wadling, Silver, Mehta, & Rothwell, 2011). Whilst the Peterson criteria class single 
domain impairment as mild cognitive impairment, other methods require at least two 
cognitive domains, and in some cases one of those domains is required to be memory, 
such as in the NINDS-AIREN criteria (Petersen et al., 2001). Pendlebury et al. (2011) 
found that in a TIA cohort with cognitive impairment, less than half had a specific 
memory impairment, suggesting that using the NINDS-AIREN criteria (Román et al., 
1993) will significantly underestimate rates of cognitive impairment. Classification of 
impairment can range from one standard deviation (SD) below the mean (Mandzia et 
al., 2016) to two SD  below the mean (Bakker et al., 2003). Using one SD point as a 
cut off for cognitive impairment may lead to false positives (van Rooij et al., 2014), 
whilst two SD cut-off points may lead to less detection of subtle changes. 
Furthermore, some studies require one test to be below the expected norm before 
classifying the domain as impaired, whilst others specify that at least half of the tests 
within that domain must fall below the norm for a classification of impairment. 
Studies may also take an average z-score from the domain to establish how far it falls 
below the mean.  
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Ensuring that clinicians and researchers are agreed on a shared understanding 
of what constitutes cognitive impairment is a key factor that needs to be agreed upon 
to address the variation within the research findings.    
1.4.3 Factors Impacting Cognitive Testing after a TIA 
1.4.3.1 Depression and Anxiety 
A recent review of the literature on stroke and TIA has shown that depression is an 
important comorbidity, with a combined prevalence rate of between 11 and 63%. 
Furthermore, studies have found that 50% of patients who were depressed at three 
weeks post-event remained so at one year. People with depression are more likely to 
have longer hospital stays and higher rates of functional disability. They are also less 
likely to be discharged home. There is a three times greater mortality risk for 
depressed patients even after accounting for the severity of the stroke or TIA and after 
accounting for demographics factors (Swartz et al., 2016). Recently, a study identified 
that TIA patients with depression are more likely to have impaired processing speed 
(Mandzia et al., 2016). It is suggested that the high rates of depression may be due to 
preserved insight in this population, and undetected structural changes in white 
matter, which could potentially influence symptoms of depression (Pendlebury, 
2009). Pendlebury et al. (2011) found that cognitive impairment following TIA was 
associated with a trend towards a higher score on the Geriatric Depression Scale 
(GDS). This finding is supported by a recent longitudinal study, which showed that 
scores on the GDS at the time of TIA and stroke, and six months later, significantly 
predict cognitive impairment two years later. Together these findings suggest 
depression and its relationship to cognitive impairment is an important factor to 
consider after TIA.  
 39 
Anxiety symptoms are also known to increase after a TIA or stroke, with 
around a 20–30% prevalence rate (Barker-Collo, 2007; Broomfield, Quinn, Abdul-
Rahim, Walters, & Evans, 2014; Leppävuori, Pohjasvaara, Vataja, Kaste, & 
Erkinjuntti, 2003). However, anxiety does not have the same predictive value on 
recurrent cerebrovascular events that depression has (Yu et al., 2015), or the same 
impact on cognitive impairment, but it significantly interacts with depression to 
influence its severity and course (Shimoda & Robinson, 1998).  
1.4.3.2 Fatigue 
Fatigue is multi-dimensional and comprises physical, emotional and cognitive 
elements. It is estimated that one third of patients experience and report fatigue after a 
TIA (Coutts et al., 2012; Moran et al., 2014), with studies reporting significant rates 
of fatigue up to 12 months later (Kjörk et al., 2015; Moran et al., 2014). A recent 
study found that TIA patients had a 43% increase in risk of experiencing fatigue 
compared with controls (Turner, Calvert, Feltham, Ryan, & Marshall, 2016). Studies 
on stroke have associated fatigue with reduced quality of life and increased mortality. 
It would be expected that TIA has a similar sequelae. Although studies have 
established that cognitive impairment and fatigue are both common after a TIA, there 
has been no investigation of the relationship between fatigue and cognitive 
performance in this group. This would be valuable to ensure fatigue is considered 
when carrying out cognitive testing.   
1.4.4 Summary 
Studies on cognition in TIA have been difficult to compare and draw conclusion from 
due to their heterogeneity across many aspects of the research process.  
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Furthermore, depression, anxiety and fatigue appear to have higher prevalence 
rates among people who have experienced a TIA or mild stroke. This may be due to 
structural changes in the brain or the impact of a TIA or stroke on their quality of life. 
There is a suggestion that such clinical factors have further independent effect on 
cognition. It is important to measure their effect on cognitive testing and whether they 
are responsible for further reductions in cognitive functioning.  
1.5 Evaluation of Current Screening Tools 
The two most commonly used screening tools are the MoCA and MMSE. However, a 
significant amount of cognitive dysfunction is still undetected in stroke settings 
(Jaillard, Naegele, Trabucco-Miguel, LeBas, & Hommel, 2009).  
The MMSE (Folstein, Robins, & Helzer, 1983) is a 30-point tool consisting of 
11 items assessing various cognitive functions including attention, orientation, 
memory, registration, recall, calculation, language and ability to draw a complex 
polygon. It takes between five and seven minute to administer. Cut-offs vary 
depending on the clinical setting in which the test is being administered and whether 
the test is used to screen for dementia or mild cognitive impairment. The conventional 
cut-off for screening for dementia is 24, although lower cut offs have been suggested 
(Creavin et al., 2016).  
A recent systematic review concluded that the MMSE is only appropriate to 
measure vascular dementia and not milder levels of cognitive impairment (Burton & 
Tyson, 2015a). The MMSE has been criticised for its insensitivity to the cognitive 
domains that are most affected in cerebrovascular disease.  For example, one third of 
the possible points on the MMSE are allocated to correct orientation for time and 
place. It is unlikely that people with mild cognitive impairments following a TIA will 
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be unable to score maximum points in this domain. Similarly, naming is unlikely to be 
impaired in this group. It has been shown that the MMSE is not as accurate in 
estimating cognitive abilities as other measures (Blackburn, Bafadhel, Randall, & 
Harkness, 2013). There are mixed findings on its predictive validity and criterion 
validity, studies have generally shown the MMSE to have low sensitivity (Van 
Heugten, Walton, & Hentschel, 2015). However, it is still a significant predictor of 
impairment and future stroke following TIA (Dong et al., 2013). 
Another more recently developed screening tool is the MoCA (Nasreddine et 
al., 2005). The MoCA was designed to be more sensitive to mild cognitive 
impairment than the MMSE as it contains a measure of executive functioning. The 
MoCA is of a similar design to the MMSE in that it is a 30-point test split into six 
different domains: short-term memory, visuospatial abilities, executive function, 
attention, concentration and working memory, language and orientation.  
There is generally a lack of consensus on the optimal cut-off for cognitive 
impairment in stroke and TIA. A cut-off of <26 out of 30 for mild cognitive 
impairment was derived from a memory clinic population (Nasseredine et al., 2005), 
although this may not be appropriate for detecting impairment in cerebrovascular 
disease. Suggested cut-offs have also varied depending on whether testing is carried 
out in the acute phase, sub acute phase or chronic phase. In studies that have looked at 
the optimum sensitivity and specificity in the acute phase, normality ranges from 19 
to 22 (Dong et al., 2012; Godefroy et al., 2011; Salvadori et al., 2013; Wong et al., 
2013), whereas in the sub acute or chronic phase cut-offs for normality range from 20 
to 27 (Cumming et al., 2013; Pendlebury, 2013; Wong et al., 2009; Wong et al., 2012; 
Wu et al., 2007). Previous UK studies looking at impairment in TIA have 
recommended the following cut-offs for the MMSE and MoCA: scores below 20 on 
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the MoCA are classed as significant impairment, 20–24 scores as mild cognitive 
impairment and scores of 25 and above as no impairment. MMSE scores below 23 are 
classed as significant impairment, 24–26 scores are mild cognitive impairment and 
scores of 25 and above are no impairment (Pendlebury, Cuthbertson, Welch, Mehta, 
& Rothwell, 2010; Pendlebury et al., 2012; Webb et al., 2014). 
A recent review examined 16 different instruments used for cognitive 
screening in the acute phase after a stroke. The MoCA proved to be the best current 
tool.  Numerous studies have shown that the MoCA is more sensitive than the MMSE 
in detecting cognitive impairment (Damian et al., 2011; Pendlebury et al., 2012; 
Popović, Šerić, & Demarin, 2007).  
However, there are still concerns over the MoCA, particularly the ceiling 
effects; six points are allocated to correct orientation and three to naming of pictures. 
It is known that most people who have a TIA return to their employment, meaning 
that test of orientation and naming are unlikely to detect the mild deficits likely to 
cause problems in everyday functioning for TIA patients with mild cognitive 
impairments. Furthermore, the MoCA’s high sensitivity tends to be associated with 
low specificity (Godefroy et al., 2011). Pendlebury et al. (2011) compared the MoCA 
and Addenbrookes Cognitive Assessment Revised (ACE-R), which includes the 
MMSE, with the NINDS-VCI 60-minute battery. They found that the MoCA and 
ACE-R were both better at detecting mild cognitive impairment than the MMSE 
alone, but that both the MoCA and ACE-R were not as sensitive to single domain 
impairments. This was hypothesised as due to the lack of timed tasks needed to 
measure information processing speed, and supported by the Chan et al. (2014) study. 
They compared a mild stroke cohort on the MoCA to a full neuropsychological 
battery and found that over three quarters of participants who scored ‘intact’ on the 
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MoCA scored as impaired on a full neuropsychological battery, of which one third 
were impaired in one domain and two thirds impaired in two or more domains. The 
majority of impairments were seen in information processing speed and non-verbal 
memory, suggesting the MoCA did not accurately detect these deficits. They also 
found that more than half of the group scored the maximum points on the MoCA for 
attention, yet were impaired on the full neuropsychological battery for this domain. 
Similarly, one third who scored in the memory and visuospatial domain were 
impaired on the full battery. This suggests that the MoCA is not finely calibrated to 
detect milder impairments and thus is likely to underreport impairments. Therefore, 
an improved screening tool would be useful, which has adequate sensitivity for the 
detection of cognitive impairment associated with vascular aetiologies.   
Both tests take the approach of covering multiple domains, but providing a 
very basic or easy test for each to assess for impairment within a domain. An 
alternative suggestion for a brief screening would be to use tests that have less of a 
ceiling effect and cover a wider range of ability. This allows for improved variability 
and a more accurate measure of global cognitive function than a one-minute test of 
one domain where the participant is highly likely to reach the ceiling score.  
A measure designed in this way could incorporate tests of cognitive function 
that are known to require a high cognitive load across multiple domains. This means 
that the test could still give an indication of impaired domains even at a screening 
level. 
1.5.1 Summary  
The MoCA and the MMSE are the most widely used screening tools for mild 
cognitive impairment, but both still fail to detect impairments, both take the approach 
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of simplified screening across multiple cognitive domains, which often means that 
TIA participants reach the ceiling of the test.   
1.6 Brief International Cognitive Assessment for Multiple Sclerosis 
(BICAMS) 
The literature suggests that there is a need for a brief monitoring instrument due to the 
MoCA and MMSE celling effects. The tool would be used during time-limited, 
routine appointments by a range of health professionals. It would need to be sensitive 
to subtle neurological deficits. Moreover, the measure would require sufficient 
psychometric properties to allow accurate cognitive evaluations. Cognitive screening 
tools should have 80% sensitivity and specificity (Lincoln, Nicholl, Flannaghan, 
Leonard, & Gucht, 2003). A monitoring instrument needs to be used that can test 
multiple areas of functioning across different anatomical brain regions and networks.  
A 15-minute brief test that covers the full range of ability has been designed in 
multiple sclerosis (Brief International Cognitive Assessment for multiple sclerosis 
(BICAMS; Langdon et al., 2012). BICAMS includes the SDMT (Smith, 1982), Trials 
1–5 of the CVLT-II (Delis, Kaplan, & Kramer, 1987) and Trials 1–3 of the Brief 
Visuo-Spatial Memory Test-Revised (BVMT-R; Benedict, Schretlen, Groninger, 
Dobraski, & Shpritz, 1996). An international panel of experts chose these three tests, 
whose psychometric properties, clinical utility and external validity were considered 
before inclusion in the measurement tool. BICAMS assesses information processing 
speed, verbal memory and visual memory. These are distributed central nervous 
system processes, which require multiple cognitive skills. Determining them may 
more accurately measure the structural and functional integrity of the brain. Other 
brief cognitive assessments, such as the MoCA and the MMSE, attempt to measure a 
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range of focal deficits, but cover a smaller spread of ability, whereas BICAMS 
assesses only information processing speed and memory across a wide range of 
performance levels. Furthermore, studies have shown SDMT to be as good at 
detecting cognitive impairment as the MoCA and the MMSE, although insensitive to 
amnestic impairments (Dong et al., 2014; Lin et al., 2016). The addition of a verbal 
and visuospatial test of memory would detect amnestic impairments and impairments 
in visuospatial abilities, which are also shown to be prevalent in this population (Chen 
et al., 2015; Pendlebury et al., 2012; Sachdev et al., 2004; Sörös et al., 2015). 
Furthermore, tests of information processing speed, verbal and visual memory have 
been shown to predict cognitive decline (Tham et al., 2002).  
BICAMS is well validated in MS, demonstrating good correlations with MRI 
parameters (Langdon et al., 2012). Several validation studies have shown that it is as 
sensitive to cognitive impairment as the recommended 90-minute gold-standard MS 
battery of tests (Dusankova et al., 2012; Eshaghi et al., 2012; O’Connell et al., 2004; 
Spedo et al., 2015; Strober et al., 2009). 
BICAMS does not provide a full assessment, but would need to provide 
sufficient information to help clinicians identify areas of difficulty. A cognitive 
screening identifies people who would benefit from a more in-depth cognitive 
assessment. Once cognitive deficits are understood people can receive appropriate 
support. 
1.7 Summary and Synthesis  
This introduction has described the current developments in standardising a 60-minute 
battery that is used internationally to advance our understanding of VCI, particularly 
in mild stroke and TIA. The importance of current and cohesive norms, which are 
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underdeveloped for this battery in the UK, has been highlighted. Following this, the 
TIA diagnosis, risk factors, prevalence of cognitive impairment and description of 
gaps in current treatment were examined. Furthermore, evidence from the literature of 
deficits in executive function and information processing speed and other areas of 
cognition was discussed. The current screening tools to assess cognition and their 
limitations were considered, besides the challenges of neuropsychological testing. 
Finally, BICAMS was proposed as an alternative brief cognitive test. This  may be 
useful in identifying the cognitive impairment in TIA. Following these assertions, the 
research questions and hypotheses of this study are set out below.  
1.8 Study Aim and Hypotheses 
The study aims to:  
! Compare established cut-offs for the MoCA, MMSE and BICAMS in a UK 
population-based sample.  
! Understand the impact of fatigue and depression on each of the screening tools 
in a UK population-based sample.   
! Calculate cuts-off for the NINDS-VCI using a UK population-based sample.  
! Calculate new cuts-off for detecting cognitive impairment using the MMSE 
and the MoCA using cuts-offs established from the NINDS-VCI battery.  
! Compare how established norms for the NINDS-VCI compare with norms 
established from a UK sample.  
 
Hypothesis 1  
Published norms for the NINDS-VCI battery will provide significantly different cut- 
offs compared with the cut-offs established from a current healthy UK sample.  
Hypothesis 2  
 47 
BICAMS will be more sensitive than the MoCA and MMSE at detecting participants 
who fall below the expected level on the NINDS-VCI battery.   
Hypothesis 3  
BICAMS will be able to identify correctly participants who fall below the expected 
level on the NINDS-VCI.   
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2 Pilot Study Method 
A pilot study of 94 healthy participants utilised a 30-minute brief battery of the 
MMSE, MoCA, BICAMS, Hospital Anxiety and Depression Scale (HADS) and 
Fatigue Severity Scale (FSS). The purpose of the pilot study was to look at the 
relationship between BICAMS and other measures that are currently used for 
assessing cognition in TIA, such as the MMSE and MoCA. The pilot study allowed 
us to consider how feasible and acceptable administration was of the screening tests 
and whether the information gathered was adequate to answer the research questions 
or whether more information or additional testing was required to answer the research 
question.   
2.1 Ethical Considerations 
The study was reviewed by Royal Holloway, University of London Ethics Committee 
and was suitable for self-certification (Appendix 1). All participants gave written 
informed consent. Potential ethical issues were considered and addressed.   
2.1.1 Informed Consent   
Although cognitive deficits in the general population are uncommon, it is important to 
consider informed consent. The BPS professional practice guidelines were considered 
and adhered to. Clear leaflets were used explaining the study and participant 
involvement (Appendix 2).    
2.1.2 Confidentiality and Storage of Data  
Test data and demographic information were anonymysed. The anonymous data were 
kept in a locked drawer on university premises. The data has now been archived at 
Royal Holloway, University of London.  
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2.1.3 Distress and Fatigue of Participants  
It was considered that participants may become distressed if they felt they were not 
performing well, or they became fatigued from the battery of tests. Therefore, all 
participants were informed that they could stop the test and withdraw consent at any 
time. They were offered breaks throughout if they wished to take them.     
2.2 Participants  
A sample of healthy male and female adults across different ages participated 
in the study. Data from 94 participants were used: 53 female, 37 male and four 
unknown. The mean age of the group was 48.64 years (with a range of 22–69 years). 
This age range was chosen as without neuroimaging, it was felt necessary to exclude 
participants above the age of 69 so as to minimise any confounding concomitant age 
related white matter changes which were not linked to VCI and TIA. Furthermore, 
people aged 22-69 are more likely to be in employment, they are likely to experience 
a more chronic and severe VCI pathway over a more prolonged period of time, and 
this is more likely to affect their quality of life in terms of  the family, social and 
economic burden.  
2.2.1 Data Collection and Recruitment  
Recruitment was completed between May 2016 and July 2016. Three masters 
students, who had received training in the administration of the tests, recruited and 
tested participants. The testing was scored by the researcher and re-scored by the 
researcher’s supervisor and a PhD student to ensure accuracy and consistency. All of 
the analyses were carried out by the researcher.  
Participants volunteered to take part and were not compensated for their 
participation. They were all recruited opportunistically through friends and family of 
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the students. All participants who expressed an interest in the study were sent an 
information sheet (Appendix 3). Participants were given 24 hours to consider the 
information and were encouraged to ask any questions they had about the study via 
email or telephone. Written consent was obtained at the start of the appointment.  
2.2.2 Inclusion Criteria  
All participants were 18 years or above, fluent in English, able to read and give their 
informed consent for participation in the study.   
2.2.3 Exclusion Criteria 
Participants were excluded if they had a prior diagnosis of dementia, the experience of 
a major psychiatric disorder, current or prior history of alcohol and drug abuse, prior 
neurological disease, which can influence cognitive function, or a history of head 
injury.   
2.3 Measures 
2.3.1 Demographic Information 
Information regarding gender and age were collected from participants.  
2.3.2 Questionnaires  
Participants were asked to complete a brief questionnaire on their levels of fatigue as 
well as a brief screening measure for depression and anxiety. Each of these will be 
described in turn.   
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2.3.2.1 Fatigue Severity Scale (FSS; Krupp, LaRocca, Muir-Nash & Steinberg, 
1989) 
This self-report measure is used to provide a subjective measure of levels of fatigue. 
The questionnaire consists of nine questions relating to everyday life. Participants are 
asked to circle the number that represents how they feel about the statement, ranging 
from 1, strongly disagree with the statement, to 7, strongly agree (Appendix 4). The 
total score can be averaged to obtain a mean score of 1–7 for each participant. The 
psychometric properties of this scale have been validated in a stroke cohort with a 
Cronbach’s alpha of 0.86 for reliability (Lerdal & Kottorp, 2011).  
2.3.2.2 The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 
1983)  
The Hospital Anxiety and Depression Scale is a brief self-report measure of anxiety 
and depression. There are 14 items in total, half relating to anxiety and half to 
depression (Appendix 5). For both subscales, raw scores of between 8 and 10 identify 
mild cases, 11–15 moderate cases and 16 or above severe cases. Besides good 
homogeneity and test-retest reliability of the total scale and subscales, the dimensional 
structure and reliability of the HADS has been found to be stable across medical 
settings and age groups (Spinhoven et al., 1997). In a review of 747 papers that had 
used the HADS, Bjelland, Dahl, Haug, and Neckelmann (2002) found that Cronbach's 
alpha for HADS-Anxiety varied from .68 to .93 (mean .83) and for HADS-Depression 
from .67 to .90 (mean .82). They also noted sensitivity and specificity for both 
HADS-Anxiety and HADS-Depression of approximately .80. Crawford, Henry, 
Crombie, and Taylor (2001) provided normative data for the HADS and found that 
demographic variables have only a modest influence on test scores. There is evidence 
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that the HADS has the same properties whether it is used with the general population, 
in general practice or with psychiatric patients (Bjelland et al. 2002), making it an 
appropriate screening instrument for the current study. The measure has been 
validated in a stroke cohort (Burton & Tyson, 2015b; Spurgeon, James, & Sackley, 
2015).   
2.3.3 Neuropsychological Tests  
2.3.3.1 Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS; 
Langdon et al., 2012)    
The Oral Symbol Digits Modalities Test (SDMT; Smith, 1982) assesses processing 
speed. It requires approximately five minutes to complete. Participants are given a 
sheet of paper, which at the top has a printed key pairing each abstract symbol with a 
number of 1–9. Eight rows containing symbols on the top with a small blank square at 
the bottom are presented on the rest of the page. The examinee has a trial of the first 
10 squares, before being given 90 seconds to complete as many of the squares as 
possible by verbally stating the number associated with each symbol (Appendix 11).  
The oral SDMT has good test-retest reliability (r=. 98) (Morrow et al., 2010). It has 
significant correlations with other processing speed tests such as the Welschler Digit-
Symbol coding subtest (r=. 91) (Morgan & Wheelock, 1992).  
California Verbal Learning Test-II (Trials 1-5) (CVLT-II; Delis, Kramer, 
Kaplan, & Ober, 2000) measures new learning and verbal memory using a multiple 
trial-list-learning task (Appendix 12). The first five learning trials have been shown to 
be the most sensitive measure of new learning and verbal memory (Benedict et al., 
2012). The CVLT-II has demonstrated good test-retest reliability (r=. 82) and good 
internal consistency (.87-.89) (Delis et al., 2000). To administer the CVLT-II, the 
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examiner reads out a list of 16 words in 18–20 seconds. Participants are asked to 
recall as many words as possible in any order. The examiner records the responses 
and continues to re-read the list of words for five trials. The sixteen words are made 
up of four semantic categories. In this study the original form was used (Delis et al., 
2000). The total number of correct items recalled across all five trials was used as a 
measure of verbal memory and new learning. The CVLT-II has good test-retest 
reliability for healthy controls (Delis et al., 1987; Woods, Delis, Scott, Kramer, & 
Holdnack, 2006) 
Brief Visuospatial Memory Test-Revised (Trials1-3) (BVMT-R; Benedict et 
al., 1996) measures visual learning and memory using a multiple trial list-learning 
paradigm. For administration, participants are given an A4 sheet of paper with six 
figures on the page. They have 10 seconds to look at the page before it is removed and 
they are asked to draw as many figures as they can recall and in their correct location 
on the page (Appendix 13). The BICAMS consists of three trials of the BVMT-R. 
Participants receive one point for the accuracy of the figure and one point for the 
accuracy of the location on the page. Therefore, there is potentially 12 marks to be 
given. The BVMT-R has excellent test-retest reliability of .80 (Benedict, 1996). 
Internal consistency ranges from .96 to .97 for the three learning trials (Benedict et al., 
1996). Performance on the BVMT-R has been found to correlate with other measures 
of verbal memory and recall such as the Visual Reproduction subtest of the Wechsler 
Memory Scale–Revised (WMS-R; Wechsler, 1987) and the Rey Complex Figure Test 
(RCFT; Meyers & Meyers, 1995). The BVMT-R has excellent internal consistency on 
all measures (Benedict, 1997).  
Norms for the BICAMS were based on a healthy UK sample of 68 participants 
with a mean age of 44 (SD 10 years, range 27–60), of which 37 were female and 31 
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were male, with an average of 16 years of education (SD 2.8) and average estimated 
IQ of 111 (SD 8.8) (Orchard, 2013).  
2.3.3.2 Montreal Cognitive Assessment (MOCA; Nasreddine et al., 2005)   
The MoCA is designed to measure global cognitive function and detect mild cognitive 
impairment. It is scored out of 30 and takes 10 minutes to administer. It measures 
short-term memory, visuospatial abilities, executive function, attention, concentration 
and working memory, language and orientation (Appendix 14). The original 
validation study found a cut-off of <26 out of 30 for mild cognitive impairment, 
although this was derived from a memory clinic population (Nasseredine et al., 2005). 
It has also been identified as suitable for detecting impairment in cerebrovascular 
disease. UK studies on impairment in TIA have recommended the following cut-offs: 
scores below 20 on the MoCA are classed as significant impairment, scores between 
20 and 24 are classed as mild cognitive impairment and scores of 25 and above are no 
impairment (Pendlebury et al., 2010, 2012; Webb et al., 2014). Internal consistency 
has been assessed using Cronbach’s alpha and is above .90 for the measure (Freitas, 
Simões, Marôco, Alves, & Santana, 2012).  
2.3.3.3 Mini-Mental State Examination (MMSE; Folstein et al., 1983) 
The MMSE is an 11-item measure that covers five areas of function, namely, 
orientation, registration, attention and calculation, recall, language and copying 
(visuoconstructional abilities). The maximum possible total score is 30 points 
(Appendix 15). It is designed to measure mental impairment in the elderly, and it 
takes 5 to 10 minutes to administer. The conventional cut-off for detecting dementia is 
24. In a recent meta-analysis by the Cochrane review, a cut-off point of 24 yielded a 
sensitivity of .85 and specificity of .90 for the detection of dementia in people over 65 
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in the community and in primary care populations. UK studies of impairment in TIA 
have recommended the following cut-offs: scores below 23 are classed as significant 
impairment, scores between 24 and 26 are mild cognitive impairment and scores of 25 
and above are no impairment (Pendlebury et al., 2010, 2012; Webb et al., 2014). 
Internal consistency, assessed using Cronbach’s alpha, is .62 (Tombaugh & McIntyre, 
1992). 
2.4 Procedure   
Participants were asked to complete the standardised questionnaire to screen for 
depression and anxiety. This was followed by a questionnaire on fatigue, the MOCA, 
MMSE and BICAMS. Participants were not advised about their performance on the 
tests.  The assessment took 30 to 40 minutes to complete. The majority of assessments 
took place in people’s homes or their workplace.  
2.5 Terminology 
It was necessary to use diagnostic terminology relating to cognitive impairment and 
depression and anxiety when referring to references and cut-offs utilised by other 
authors who had used clinical samples. For the sake of clarity, the same definitional 
terms were applied. However, as the current study utilises healthy controls and a full 
and detailed clinical interview has not been carried out, it was not possible to 
determine if participants were in fact cognitively impaired or experiencing clinical 
depression or anxiety, for this reason, the term ‘falling below expected levels’ was 
used in place of ‘cognitive impairment’ when not referring to another author’s work 
and operational definitions.   
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2.6 Statistical Analysis   
2.6.1 FSS   
 Frequencies for different levels of fatigue were calculated using the following 
categories outlined by Krupp et al. (1989): sub-clinical fatigue (FSS < 4), borderline 
fatigue (4 < FSS ≤5) and fatigued (FSS > 5).  
2.6.2 HADS  
Standard cut-offs for the differing severity levels of depression and anxiety were used 
to establish the frequencies of each. Cut-off scores for depression and anxiety were 
applied: normal (0-7), mild (8-10), moderate (11-14) and severe (15-21) (Zigmond & 
Snaith, 1983). 
2.6.3 BICAMS  
Dusankova et al. (2012) suggested that if one or more BICAMS tests have a z-score 
of more than 1.5SD below the mean, BICAMS performance should be considered 
impaired. z-scores were derived using the norms from a UK normative sample as 
described in Orchard (2013).  
2.6.4 MoCA and MMSE 
Webb et al. (2015) established the cut-off for the MoCA and MMSE: a score of <20 
on the MoCA was classed as ‘significant impairment’, scores between 20 and 24 were 
‘mild impairment’ and ≥25 was ‘no impairment’. A score of <23 on the MMSE was 
classed as ‘significant impairment,’ scores between 24 and 26 were ‘mild impairment’ 
and ≥27 was no impairment. No educational adjustment was made on either test.  
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2.6.5 Relationships between Variables  
Pearson’s correlations were used to establish the relationship between the cognitive 
tests (MoCA, MMSE, BICAMS) and clinical and demographic factors (fatigue, 
depression, anxiety, age and gender).  
2.7 Section Summary  
This section presented the ethical approval process, and the participants included and 
excluded from the study. The measures and procedure for administration were 
described. This was followed by an outline of the planned statistical analyses. The 
following results section describes the statistical analyses and findings.  
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3 Pilot Study Results 
3.1 Data Screening 
Quantitative analysis of the data was carried out using IBM SPSS version 21.0 for 
Macintosh (IBM Corp., 2012). Data were screened for missing values, accuracy and 
normality prior to analyses. Descriptive statistics, histograms and box plots for each 
variable were calculated.  
3.1.1 Missing Data 
Group means were assigned to one total MoCA score (out of 30), a total HADS 
depression score (out of 21) and a total trial 2 score for one BVMT-R (out of 12). Age 
and fatigue data were unavailable for 33 participants.  
3.1.2 Outliers 
One outlier was identified (defined as data points falling more than three standard 
deviations from the mean). A CVLT-II score was found to be more than three 
standard deviations below the mean. As this was the participant’s sole outlying score, 
it was assumed to be a true representation. As recommended by Tabachnick and 
Fidell (2012), the statistical impact of the outliers was reduced by replacing the 
outlying score with the value of the next lowest in the population, plus one unit of 
measurement. This was repeated at the other end of the distribution.  
3.1.3 Normality 
Distribution was assessed to establish whether the data met the assumption of 
normally distributed data for parametric analysis. As suggested by Tabachnick and 
Fidell (2012), a z-score cut-off of between -2.58 and 2.58 for both Skew and Kurtosis 
was used to determine normality of distribution for each variable. HADS anxiety, age, 
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BICAMS and MoCA scores were all within the limits of normality z=2.57. Fatigue 
was significantly positively skewed (z = 3.20, p<01). A square root transformation 
was carried out on fatigue scores, which resulted in them being normally distributed 
(z= .837, p>01). HADS depression scores were significantly positively skewed 
(z=3.23, p<0.1). A square root transformation was carried out on HADS depression 
scores, which resulted in them being normally distributed (z= -1.57, p>0.1). MMSE 
was significantly negatively skewed (z=-3.02, p<0.1). MMSE scores were squared, 
which resulted in them being normally distributed (z=-2.51, p>0.1).  
3.2 Demographic and Clinical Characteristics 
Descriptives of demographic and clinical variables were calculated for each of the 
demographic and clinical variables of interest. These included gender, age, fatigue, 
anxiety and depression. Table 1 displays the means, standard deviations and range for 
each of the demographic and clinical variables.   
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Table 1. Demographic and Clinical Characteristics of the Pilot Group (N=94). 
 Mean   
 
 (SD) 
Range 
Age in years 48.64* 
(12.46) 
22-69 
FSS 3.78* 
(2.11) 
1.29-9 
HADS-Anxiety 5.96 
(3.92) 
0-18 
HADS-Depression  3.69 
(2.59) 
0-12 
*n=61 
3.2.1 Gender 
The ratio of male to female participants was 37:53, with gender information not 
available for four participants.  
3.2.2 Fatigue 
The Fatigue Severity Score (FSS; Krupp et al., 1989) was employed to measure 
fatigue and the following categories, as outlined by Krupp et al. (1989), were applied: 
FSS < 4 (sub-clinical fatigue), 4 <  FSS ≤ 5 (borderline fatigue) and FSS > 5 
(fatigued). Fatigue data were not available for 33 participants. Table 2 shows the 
classification frequency across participants. In total, 40% of participants were 
identified as experiencing a level of fatigue.  
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Table 2.  Classifications and Scores on the Fatigue Severity Rating Scale (FSS)  
 Number in 
Classification 
(%) 
Sub-clinical fatigue  
(FSS <4) 
37 
(60%) 
Borderline fatigue 
 (4 < FSS ≤5) 
14 
(24%) 
Fatigued  
(FSS > 5) 
10 
(16%) 
 
3.2.3 Anxiety and Depression 
Depression and anxiety were measured using the self-report Hospital Anxiety and 
Depression Scale (HADS; Zigmond & Snaith, 1983). The standard HADS 
classification and cut-off scores for depression and anxiety were applied: normal (0– 
7), mild (8–10), moderate (11–14) and severe (15–21). In total, 9% of participants 
were identified as experiencing a level of depression and 34% were classified as 
experiencing a level of anxiety.   
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Table 3. Classification and Scores on the Hospital Anxiety and Depression Scale 
(HADS) for Pilot Data (n=94). 
 Number in 
Classification 
(%) 
Sub-clinical depression  
(Scores 0–7) 
85 
(91%) 
Mild depression  
(Scores 8–10) 
7 
(7%) 
Moderate depression 
(Scores 11–14) 
2 
(2%) 
Severe depression  
(Scores 15–21) 
0 
(0%) 
Sub-clinical anxiety  
(Scores 0–7) 
60 
(64%) 
Mild anxiety 
(Scores 8–10) 
19 
(20%) 
Moderate anxiety 
(Scores 11–14) 
13 
(14%) 
Severe anxiety 
(Scores 15–21) 
2 
(2%) 
 
 
 63 
3.3 Screening Tools  
The MoCA, MMSE and BICAMs were carried out. The mean, SD and range for each 
sub-domain on each screening test are outlined in Table 4. Clinical cut-offs for the 
MoCA and MMSE were derived from established sources in the TIA literature (Webb 
et al., 2014). Scores below 20 on the MoCA were classed as significant impairment, 
scores between 20 and 24 were mild cognitive impairment and scores of 25 and above 
were no impairment. In MMSE, scores below 23 were classed as significant 
impairment, scores between 24 and 26 were mild cognitive impairment and scores of 
25 and above were no impairment. In BICAMS, the established consensus is 1.5SD 
below the mean on one or more tests (Dusankova et al., 2012; O’Connell et al., 2004; 
Orchard, 2013). Norms derived from a UK population were used for BICAMS 
(Orchard, 2013).   
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Table 4. Means, Standard Deviations (SD) and Ranges for Sub-Domains of Each 
Neuropsychological Measure in the Pilot Group (N=94). 
 M 
(SD) 
Range 
MoCA 25.66 
(2.44) 
18-30 
Short-Term Memory 3.72 
(0.56) 
0-5 
Visuospatial Abilities 3.04 
(0.66) 
1-4 
Executive Function 3.72 
(0.56) 
1-4 
Attention, Concentration & 
Working Memory 
5.58 
(0.70) 
3-6 
Language 4.94 
(0.29) 
3-5 
Orientation 5.95 
(0.23) 
5-6 
MMSE 28.25 
(1.49) 
24-30 
Orientation 7.89 
(0.34) 
6-8 
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Registration 3.00 
(0) 
3-3 
Attention and Calculation 4.65 
(0.80) 
1-5 
Recall 1.81 
(1.24) 
0-3 
Language 7.89 
(0.27) 
6-8 
Visuospatial Abilities 0.96 
(0.20) 
0-1 
BICAMS 111.05 
(20.59) 
86-110 
BVMT-R Total Learning 20.54 
(7.38) 
2-36 
CVLT-II Total Learning 45.73 
(9.90) 
26-68 
SDMT 53.04 
(11.22) 
25-85 
 
3.4 Number of Participants Falling Below Established Cut-Offs  
Frequencies of participants falling below the expected level on the MoCA, MMSE 
and BICAMS are provided in Table 5. Overall, 32% of participants fell below 
expected levels on the MoCA, 10% on MMSE and 69% on BICAMS. BICAMS 
classified the highest number of participants as falling below the expected level. 
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Twelve participants were impaired across all three BICAMs measures. Seventeen 
people were impaired across BVMT-R and CVLT-II, four people on SDMT and 
CVLT–II and five people on BVMT-R and SDMT. BICAMS identified 29 (97%) of 
the 30 participants in the impaired range on the MoCA and nine (100%) participants 
in the impaired range of the MMSE. The MoCA also identified all nine participants of 
the impaired range on the MMSE.  
Table 5. Participants Falling Below Established Cut-Off Scores on the Montreal 
Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE) and Brief 
International Cognitive Assessment Measure (BICAMS) in the Pilot Group (N=94). 
 MoCA MMSE BICAMS 
 Number in Classification 
(%) 
Significant Impairment  1 
(1%) 
0 
(0%) 
65 
(69%) 
Mild Impairment  29 
(31%) 
9 
(10%) 
 
No Impairment 64 
(68%) 
85 
(90%) 
 
 
3.5 Relationships Between Variables  
Pearson’s correlation was used to establish the relationship between the cognitive 
tests and fatigue, depression, anxiety and age and gender. Results are shown in Table 
6. 
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Table 6. Summaries of Correlations between Neuropsychological Measures and 
Fatigue, Anxiety and Depression for Pilot Group (N=94). 
 BICAMS 
z-score 
MMSE MoCA FSS 
(n=61) 
Depression Anxiety 
MMSE .41**      
MoCA .50** .45**     
FSS (n=61) .02 -.08 -.08    
Depression .00 -.06 -.03 .40**   
Anxiety .09 .06 .09 .31* .40**  
Age (n=61) -.55** -.37** -.32** -.09 -.22 -.36** 
Gender 
(n=90) 
.09 .09 .03 -.09 -.11 .08 
*p<. 05, **p<. 01 
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3.6 Summary of Pilot Data  
Thirty-two percent of participants fell in the impaired range on the MoCA, 10% on 
MMSE and 69% on BICAMS. Despite the high number of participants scoring in the 
clinical range for fatigue (40%) and anxiety (34%), no significant correlations were 
found between fatigue, depression or anxiety in any of the screening tests. Gender 
was not significantly correlated with any of the screening tests. However, age was 
significantly negatively correlated with all three screening tests.   
In summary, BICAMS seems to be a potential candidate for a suitable 
screening tool for mild cognitive impairment.   
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4 Pilot Study Discussion  
The pilot study was carried out to look at the feasibility of the BICAMS and to draw 
comparisons between the measures. The results showed that BICAMS was highly 
correlated with the MoCA and the MMSE. This suggested that BICAMS could be a 
useful tool, which could potentially improve the sensitivity and specificity to detect 
cognitive impairment in TIA participants.  
There were no significant correlations between any of the screening measures 
and fatigue, depression or anxiety, despite the high number of participants scoring in 
the clinical range within these demographic variables. There was a significant 
negative correlation with age, suggesting that performance on the tests declines with 
age. Currently, none of the tools account for variance in age and how this may affect 
performance. This may be because the MoCA and MMSE have been mainly utilised 
in elderly populations rather than across the whole age range.  
4.1 Interpretation    
4.1.1 BICAMS is Positively Correlated with the MoCA and MMSE  
This would suggest that all three tools measure cognition. Further exploration of the 
tools is required to determine how closely each compares with a full battery of 
neuropsychological tests and whether other clinical or demographic variables may be 
partially correlated with the measures. 
4.1.2 Age is Significantly Negatively Correlated with BICAMS, MoCA and MMSE  
This finding is in line with other studies showing that age is a significant predictor of 
neuropsychological testing scores (Reitan & Wolfson, 1995). Generally, research has 
focused on exploring the use of the MoCA and MMSE in an older population. This 
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pilot study has highlighted that if screening tools are to be used across a broader age 
range, it is important to account for age effects. It is likely that some tests within each 
of the screening tools are likely to be affected by age in varying degrees. For example, 
tests of information processing speed, such as the SDMT in the BICAMS and verbal 
fluency tasks in the MoCA and MMSE, may be more highly influenced by age than 
the orientation tasks in the MoCA and MMSE.   
4.1.3 Gender is not Significantly Correlated with BICAMS, MoCA or MMSE 
Studies of neuropsychological testing have generally shown that gender is not 
significantly correlated with neuropsychological test performance. It is important to 
consider other cultural factors, which may sometimes account for differences in 
performance; for example, ensuring that years of education do not differ between 
male and female participants.  
4.2 Strengths and Limitations 
4.2.1 Clinical and Demographic Information 
A relative strength of the study is the collection of further clinical information on 
depression, anxiety and fatigue. It is interesting to note that these clinical factors do 
not correlate with the screening measures despite relatively high numbers of 
participants in the clinical range. Future studies should continue to collate information 
on clinical factors such as anxiety, depression and fatigue to see how rates differ in a 
TIA population and if these clinical factors are correlated with screening tools in a 
TIA population. This may provide more information on how anxiety, fatigue and 
depression are experienced within the TIA population and if this is different to 
anxiety, depression and fatigue in the general population.  
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No information on years of education was collected from participants, 
meaning that no adjustment was made on any of the screening tools for participants 
with lower than average educational experience. Neither BICAMS nor the MMSE 
adjust scores for years of education. However, the MoCA awards one additional point 
for less than 12 years of education. This was not possible to conduct in the pilot study. 
Future studies should ensure accurate information on years of education to explore 
how this demographic factor relates each of the cognitive tests.  
4.2.2 Level of Impairment in a Non-Clinical Sample  
A high proportion of participants were classified in the impaired range on all three 
screening tools. The highest numbers were identified by the BICAMS, followed by 
the MoCA and then the MMSE. Such findings are not uncommon with control studies 
(Binder, Iverson, & Brooks, 2009; Schretlen, Testa, Winicki, Pearlson, & Gordon, 
2008) and highlight the importance of considering test scores in the wider context of 
the participant’s wellbeing.  
4.2.3 Rigour of Marking Procedure  
A relative strength of the pilot study was the rigour of the marking procedure, in 
which all tests were scored and then ratified by a second marker. This ensured a high 
level of consistency across participants within the pilot group.  
4.2.4 Normative Data  
The age of participants in this sample fell outside the age range in which BICAMS 
normative data have been collected. Furthermore, as no information on years of 
education or IQ was provided in this sample, it is difficult to know if the normative 
data for BICAMS accurately reflect the sample of participants in this study. Future 
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studies should consider collecting further demographic information to aid with 
matching the group to a similar normative sample data set.  
4.3 Clinical and Research Implications  
To understand more why the measures are correlated, it would be helpful to compare 
the screening tools with a larger battery of neuropsychological tests that fully explore 
multiple domains of cognitive functioning. Future studies should continue to collect 
information on clinical factors such as depression, anxiety and fatigue and consider 
collecting supplementary information on demographic factors such as years of 
education and IQ, in order to understand the population further. Investigation into if 
an age-adjusted score is necessary should also be explored.  
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5 NINDS-VCI Group Method 
5.1 Ethical Considerations 
Ethical considerations for both the pilot and NINDS-VCI group can be found in 
Section 2.1.   
5.2 Participants  
A sample of healthy male and female adults across different ages and different 
educational backgrounds participated in the study. Data from 67 participants were 
used in the 90-minute test group. This comprised 44 female and 23 males. The mean 
age of the group was 43.86 (range 18–67). Mean years of education was 16.24 (range 
10–24).  
5.3 Data Collection and Recruitment  
Recruitment was completed between August 2016 and February 2017. The researcher 
recruited and tested participants for the 90-minute battery, and a psychology graduate 
trained in the administration of the test battery recruited and tested a further nine 
participants. The testing was scored by the researcher and re-scored by the research 
supervisor and a PhD student to ensure accuracy and consistency. The researcher 
carried out all analyses.  
Participants volunteered to take part and were not compensated for their 
participation. They were all recruited opportunistically in London, the Midlands and 
Surrey. Posters were distributed in a London hospital to recruit participants. All 
participants who expressed an interest in the study were sent an information sheet 
(Appendix 3). Participants were given 24 hours to consider the information and were 
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encouraged to ask any questions they had about the study via email or a telephone 
call. Written consent was obtained at the start of the appointment.  
5.3.1 Inclusion and Exclusion Criteria  
The inclusion and exclusion criteria for both the pilot study and main study are given 
in sections 2.2.2 and 2.2.3.  
5.3.2 Individuals Excluded  
Of the potential participants expressing an interest, 69 took part and 67 were included 
in the analysis. Reasons for exclusion were history of head injury or epilepsy (n=1) 
and withdrawal before the end of testing (n=1).  
5.3.3 Sample Size 
Regression analysis was planned to investigate which factors contributed to a 
significant amount of the variance in NINDS-VCI and BICAMS scores. An a priori 
power analysis was carried out to see how many participants were needed to have a 
power of .80 at a 0.5 level. This is to ensure that the prediction equation has 
generalisability. It was calculated that a total of 40 participants were required to 
complete the neuropsychological battery to ensure adequate power for a large effect 
size. This was calculated using G*power 3.1.3 (Faul, Erdfelder, Lang, & Buchner, 
2007), with a traditional p-value of .05 and power value of .80 (Cohen, 1992).  
5.3.4 Retrospective Power Analysis  
A post hoc power analysis was conducted using the software package G*Power (Faul, 
Erdfelder, Lang, & Buchner, 2007). The sample size of 67 was used for the statistical 
power analyses and a four predictor variable equation was used as a baseline. The 
recommended effect sizes used for this analysis were as follows: small (f 2 = .02), 
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medium (f 2 = .15) and large (f 2 = .35) (Cohen 1992). The alpha level used for this 
analysis was p < .05. The post hoc analyses revealed the statistical power of this study 
was .948 for detecting an effect. Thus, there was more than adequate power (i.e., 
power * .80) at the moderate to large effect size level.  
5.4 Measures 
The tests administered to both the pilot group and 90-minute test battery group are 
discussed in section 2.3.  
5.4.1 Neuropsychological Tests  
5.4.1.1 National Institute for Neurological Disorders and Stroke Test Battery for 
Stroke- (NINDS-VCI; Hachinski et al., 2006)   
Participants in the 90-minute test battery group all completed the NINDS-VCI tests. 
The battery is used in stroke and TIA research, with an administration time of 60 
minutes. The battery is drawn from seven different neuropsychological assessments, 
which are discussed below. The normative data selected for each test are also 
described. Cronbach’s alpha of the cognitive tests within NINDS-VCI is 0.87; intra-
rater reliability as measured by ICC (95% CI) was 0.90 (0.66-0.97) (Chen et al., 
2015).  
The Trail Making Test (Part A and B) (TMT; Ivnik et al., 1996; Reitan, 1955) 
is a measure of attention, speed and mental flexibility. In Part A, participants are 
asked to connect the numbers in ascending order with a pencil, while they are timed. 
The numbers run from 1–25 and scattered across an A4 page. In Part B, participants 
are asked to alternate between connecting numbers and letters in ascending order 
(e.g., 1, A, 2, B, 3, C…) to 13 and L (Appendix 6). Part B requires the use of divided 
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attention and set shifting. Studies have shown age to be a significant contributor to 
scores, with education making a moderate contribution and gender making a non-
significant contribution (Mitrushina, Boone, Razani, & D’Elia, 2005). Reliability is 
high, although this may not be reliable across populations and time intervals (Strauss 
et al., 2006). Inter-rater reliability has been reported as .94 for Part A and for Part B 
(Fals-Stewart, 1992). The test has been shown to be sensitive to cerebrovascular 
dementia (Barr, Benedict, Tune, & Brandt, 1992).  
The norms suggested by Hachinski et al. (2006) were provided by Selnes et al. 
(1991) for 733 males ranging from 25 to 54 years of age, with a mean age of 37 years 
(SD: 7.6) and a mean of 16 years (SD: 2.3) of education. The majority (92%) of the 
sample were white non-Hispanic, 4% white Hispanic, 2% black non-Hispanic and the 
remaining few belonged to the other racial categories.  
Boston Naming Test (15-item version) (BNT; Mack et al., 1992) assesses 
visual naming, language and lexical retrieval. Participants are presented with 15 black 
and white line drawings of everyday objects and asked to name each one (Appendix 
7). Reliability co-efficients vary from .49 to .84 (Schefft, Testa, Dulay, Privitera, & 
Yeh, 2003). The BNT correlates highly with other language measures, such as the 
Visual Naming Test of Multilingual Aphasia Examination (r=. 76 to .86). A study has 
shown that the BNT is able to detect differences between controls and those with 
white matter infarcts in the brainstem (van Zandvoort, de Haan, van Gijn, & Kappelle, 
2003).   
The norms suggested by Hachinski et al. (2006) were provided by Fastenau et 
al. (1999) based on a sample of 108 healthy individuals, aged 57 to 85 years (M 72.2, 
SD 7.0), in the United States. The sample was predominantly Caucasian (95%) and 
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well educated (97% had at least 12 years of education). Data were stratified by three 
age-adjusted categories.  
Rey-Osterrieth Complex Figure Copy (RCFT; Fastenau, Denburg, & Hufford, 
1999) measures organisational and visuoperceptual skills. Participants were first 
shown a complex geometric figure and asked to draw the same figure. Immediately 
after the copy trial, they were instructed to draw the design from memory. After a 30-
minute delay, they were asked to draw the figure from memory again (Appendix 8).  
Both split-half and coefficient alpha reliabilities were greater than .60 (Strauss et al., 
2006). The reliability and validity of the RCFT has been described by Meyers and 
Meyers (1995). Range from .93 to .99 indicates excellent inter-rater reliability. 
Pearson correlations were .75 for the immediate trial and .88 for the delayed. The 
RCFT also has good construct validity and correlates with other tests. The convergent 
and discriminant validity shows that it is a measure of visuospatial constructional 
ability and visuospatial memory.  
The norms suggested by Hachinski et al. (2006) were provided by Fastenau et 
al. (1999), who conducted tests involving 211 healthy American adults. Ages ranged 
from 30 to 85 years (M 62.9, SD 14.2), education ranged from 12 to 25 years (M 14.9, 
SD 2.6), 55% were women and 45% were male, and over 95% were Caucasian.  
Hopkins Verbal Learning Test-Revised (HVLT-R; Benedict et al., 1998; 
Brandt, 1991) measures strategic learning and episodic memory indices. A list of 12 
words from three semantic categories is read out to the examinee. There are three 
learning trials, a delayed recall trial and a recognition trial of 24 words, 12 target and 
12 non-target words, six of which are drawn from the same semantic category. Form 1 
was used in the current research study (Appendix 9). Reliability coefficients for the 
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four primary HVLT-R variables are .74 for Total Recall, .66 for Delayed Recall and 
.40 for the recognition trial (Benedict & Zgaljardic, 1998).  
The norms suggested by Hachinski et al. (2006) were provided by Benedict et 
al. (1998), in their study of 541 American subjects. The average age of the sample 
population was 48.1 years (SD 17.3), with a range from 17 to 88 years. The education 
level ranged from 5 to 20 years, with a mean of 13.8 (SD 2.3). There were 200 (37%) 
men in the sample and 341 (63%) women.  
Letter (Controlled Oral Word Association Test) Fluency (COWAT; Benton et 
al., 1994) is a measure of phonemic fluency and evaluates the spontaneous production 
of words.  The participant is asked to produce as many words as he or she can in 
60 seconds beginning with a particular letter. Three separate trials are given with three 
different letters. The letters C, F, L were used in this research. Internal reliability is 
reported to be high (r=0.83) (Ruff, Light, Parker, & Levin, 1996). Inter-rater 
reliability is also high (.99) (Laukka, Jones, Small, Fratiglioni, & Bäckman, 2004)  
The norms suggested by Hachinski et al. (2006) were provided by Ruff et al. 
(1996), in their study of 360 volunteers aged between 16 and 70. All participants were 
native English speakers and resided in California and Michigan. Four education 
groups and three age groups were provided.  
Category (animals) Fluency (Issacs & Kennie, 1973) is a measure of semantic 
fluency and also evaluates the spontaneous production of words. It requires 
participants to list as many animals as possible within the 60-second time limit. 
Baldo, Shimamura, Delis, Kramer and Kaplan (2001) reported that the test re-test 
reliability is good to high, and the test has good correlations with other verbal fluency 
tests, such as COWAT (FAS) (r = .52 (p < .01)) (Tombaugh, Kozak, & Rees, 1999).  
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The norms suggested by Hachinski et al. (2006) were provided by Selnes et al. 
(1991), in their study of 733 males ranging from 25 to 54 years of age, with a mean 
age of 37 years (SD: 7.6), and a mean of 16 years (SD: 2.3) of education. The 
majority (92%) of the sample were white non-Hispanic, 4% white Hispanic, 2% black 
non-Hispanic and the remaining few belonged to the other racial categories.  
WAIS-IV Digit-Symbol Coding Test: Wechsler Adult Intelligence Scale-Fourth 
Edition (WAIS-IV, Wechsler, 2008) (Appendix 10). The WAIS-IV
 
is a 
comprehensive test battery with excellent psychometric properties. A large 
standardisation sample of 2200 individuals means that normative data are available 
for individuals up to the age of 90. The digit symbol-coding subtest provides a 
measure of information processing speed on non-verbal visual information. The 
average split-half reliability is excellent (.93) with a test-retest stability of .87. The 
reliability and validity of the WAIS-IV
 
has been demonstrated in a wide range of 
clinical populations (Wechsler et al., 2008).   
The norms suggested by Hachinski et al. (2006) were provided by Wechsler et 
al. (2008), in their study of 2200 people across 13 age groups. The nine younger 
groups consisted of 200 participants, and 100 subjects represented each of the four 
older groups. The normative population was proportional to US census data in 2005, 
in terms of gender, race and ethnicity, with equal numbers of males and females in the 
younger groups, and the older groups containing more women.  
5.4.1.2 Intellectual Functioning  
Test of Premorbid Intellectual Functioning (TOP-F; Wechsler, 2011) was used as a 
measure of intellectual functioning (Appendix 16). Word reading is relatively 
preserved even after the loss of cognitive functioning. Participants read aloud 70 
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irregular words. The TOP-F is highly correlated with the WAIS-IV (Wechsler, 2008) 
(r=. 72), with high internal consistency and good test-retest reliability (Alpha .96 
to.99 and .89 to .95) (Wechsler, 2011).  
5.5 Procedure   
Sixty-seven healthy controls took part in the study, which included the NINDS-VCI, 
MMSE, MoCA, BICAMS and HADS and FSS and TOP-F, to determine how 
performance on the gold standard NINDS-VCI battery compares with performance on 
shorter batteries (MMSE, MoCA, BICAMS).  
5.5.1.1 Administration of the Measures  
Participants were asked to complete the HADS and the FSS. A battery of tests was 
then administered to assess premorbid intelligence, speed of information processing, 
executive functioning, language and visuospatial and memory functioning. 
Administering the tests across participants in two different orders counterbalanced test 
order. These are outlined in the table below.  
 
Table 7. Order of Test Delivery. 
Odd Participant Number Even Participant Number 
MOCA NINDS-VCI 
MMSE TOP-F 
BICAMS: SDMT, BVMT & CVLT-II MOCA 
NINDS-VCI MMSE 
TOP-F BICAMS: SDMT, BVMT & CVLT-II 
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Participants were not advised about their performance on the tests. The 
assessment took 60 to 90 minutes to complete. The majority of assessments took place 
in people’s homes or their workplace.  
5.6 Safety 
A protocol that followed the Guidance from the National Health Service Lone Worker 
Policy (NHS Security Management, 2005) was established in order to ensure the 
researcher’s safety when undertaking testing, particularly in participants’ homes. Only 
participants personally known to the researcher were seen at home.  
5.7 Statistical Analysis   
Section 2.6 provides details on the descriptive analysis for the FSS, HADS, BICAMS, 
MoCA and MMSE, and correlational analyses that apply to both the pilot study and 
the 90-minute test battery group.  
5.7.1 z-Scores  
z-scores were derived for each participant on each of the cognitive measures. The first 
was calculated by using the group mean and standard deviation. The second z-score 
was calculated using the means and standard deviations from normative data sources 
recommended by Hachinski et al. (2006). Z-scores were then used to see which 
participants fell below the expected levels, using different criteria.    
5.7.2 Defining Impairment  
The modified Peterson criteria were used to identify participants who were falling 
below expected levels and whether the impairment was across multiple domains or 
within memory domains. The following four categories were used: amnestic single 
domain impairment, amnestic multiple domain impairment, non-amnestic single 
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domain impairment, non-amnestic multiple domain impairment (Peterson et al., 
2001). Frequencies were calculated for each of the four categories at 1SD, 1.5SD and 
2SD.  For the MCI-single test definition, participants were divided into those with and 
without memory impairment on the HVLT-R immediate or delayed recall. 
Participants with impairment on the HVLT-R were then classified as MCI amnestic 
single-domain (no other tests abnormal) or amnestic multiple-domain (>1 other test 
abnormal. Participants without impairment on the HVLT-R were classified as non-
amnestic single domain if they were impaired on a single non-memory test, or non-
amnestic multiple-domain if more than one non-memory test was impaired. For the 
MCI-multiple tests definition, participants were divided into those with and without 
memory impairment on the HVLT-R immediate and delayed recall. Participants with 
impairment on the HVLT-R were then classified as amnestic single-domain (no other 
domain abnormal), or amnestic multiple domain if a non-memory domain was also 
impaired. Participants without impairment on the HVLT-R were classified as non-
amnestic single domain if they were impaired in one non-memory domain, or non-
amnestic multiple-domain if more than one non-memory domain was impaired. 
5.7.3 Norm sources  
Norms were chosen on recency and the demographic factors, which matched the 
participants of the current study as closely as possible. Norms stratified by age from 
Welschler et al.  (2008) were used for the WAIS Digit Symbol Coding. Norms 
stratified by gender and education from Ruff et al. (1996) were used for COWAT. 
Norms stratified by age from Selnes et al. (1991) were used for semantic fluency and 
TMT. Norms stratified by age from Mack et al. (1992) were used for the BNT. Norms 
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stratified by age from Fastenau et al. (1999) were used for the Rey-Osterrieth. Norms 
stratified by age from Benedict et al. (1998) were used for the HVLT-R.   
5.7.4 Test of Proportions  
Numbers of participants falling below the expected level on each cognitive test were 
totaled using both published and current norms. Total numbers of participants falling 
1.5SD below the expected level, using both norming sources, were then compared 
using a McNemar chi-squared analysis. This determined if the proportion of 
participants falling below the expected levels differed between the two methods of 
norming.  
5.7.5 Regression  
Regression analyses were performed to explore the relationship of demographic 
factors (gender, age2, years of education and estimated IQ) to NINDS-VCI scores. 
Similarly, a regression was carried out to explore the relationship of demographic 
factors to BICAMS performance. Age was squared before the analysis to account for 
non-linear age effects as suggested by Parmenter, Testa, Schretlen, Weinstock-
Guttman and Benedict (2010).  
5.7.6 Sensitivity and Specificity  
Cases were identified as falling below expected levels on the NINDS-VCI; these were 
then compared with the number of cases identified as falling below expected levels on 
the BICAMS. The accuracy, sensitivity and specificity of BICAMS were calculated in 
comparison with the NINDS-VCI. McNemar’s test of proportions was utilised to 
explore if the proportion of participants identified differed between NINDS-VCI and 
BICAMS. Suitable cut-offs for the MoCA and MMSE were explored to see which 
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cut-off point was the most sensitive and specific at identifying those who fell below 
the expected level on the NINDS-VCI battery.  
5.8 Section Summary  
This section presented the ethical approval process, and discussed which participants 
were included and excluded from the study. The measures and procedure for 
administration were considered. This was followed by an outline of the planned 
statistical analyses. The results section below describes the statistical analyses and the 
findings.   
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6 Results 90-Minute Neuropsychological Test Battery Group 
6.1 Data Screening 
Data were screened for missing values, accuracy and normality prior to analyses using 
descriptive statistics, histograms and box plots for each variable.  
6.1.1 Missing Data 
Where one participant’s age was missing, a group mean was assigned.  
6.1.2 Outliers 
Three outliers were identified (defined as data points falling more than three standard 
deviations from the mean). A TMT-B score was found to be more than three standard 
deviations above the mean. A Rey copy (RCFT) score and BNT score were also 
found to lie more than three standard deviations below the mean. All scores were 
from individual participants, and these were their only outlying scores; it was felt that 
all participants should remain in the data set. As recommended in Tabachnick and 
Fidell (2012), the statistical impact of the outliers was reduced in both cases by 
replacing the outlying score with the value of the next highest or lowest in the 
population plus one unit of measurement. This was repeated at the other end of the 
distribution.  
6.1.3 Normality 
Distribution was assessed to establish whether the data met the assumption of 
normally distributed data for parametric analysis. As suggested by Tabachnick and 
Fidell (2012), a z-score cut-off of between -2.58 and 2.58 for both Skew and Kurtosis 
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was used to determine normality of distribution for each variable. Age, years of 
education, Estimated IQ and all BICAMS measures were within normal limits.  
The Rey immediate recall test was significantly negatively skewed z=-4.62, 
p<0.1. TMT-B scores were significantly positively skewed z=5.35, p<0.1. BNT 
scores were significantly negatively skewed z=6.85, p<0.1. MoCA and MMSE scores 
were significantly negatively skewed -2.68 and -2.82, respectively. 
Based on the recommendations of Tabachnick and Fidell (2012) for positively 
skewed data, the TMT-B raw scores were transformed using the LOG10(X) function. 
This produced normally distributed data for the TMT-B score Z=1.69, p>0.1. 
Following the recommendation of Tabachnick and Fidell (2012), moderately 
negatively skewed data scores on the MoCA and MMSE were squared. This produced 
normally distributed scores for the MoCA z=2.18, p<0.1 and within the limits of 
normally distributed data for MMSE -2.69. Following the recommendation of 
Tabachnick and Fidell (2012) for severely negatively skewed data, inverse reciprocal 
transformations were used to transform the substantially negatively skewed data for 
the Rey immediate recall test and BNT 1/(k-X) function. This produced normally 
distributed scores for the Rey immediate recall z=2.01, p<0.1. However, the BNT 
remained skewed.  
6.2 Demographic and Clinical Characteristics  
Table 8 summarises participant demographic and clinical information. Measures of 
depression, anxiety and fatigue were also completed.  
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6.2.1 Gender and Age and Years of Education  
The ratio of male to female participants was 23:44. Participants’ ages ranged from 18 
to 67 (M 43.86, SD 15.51). They had spent a mean of 16.24 years in education (SD 
2.73, range 10-24).  
 
Table 8. Demographic and Clinical Characteristics of the 90-minute battery (N=67). 
 Mean 
(SD) 
Range 
Age in years 43.86 
(15.51) 
18-67 
Years in Education 16.24 
(2.73) 
10-24 
IQ (TOPF)  113.91 
(8.83) 
97-133 
FSS 3.22 
(1.13) 
1.22-6.44 
HADS-Anxiety 
5.51 
(3.14) 
0-13 
HADS-Depression 
2.67 
(2.18) 
0-9 
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6.2.2 Estimated IQ 
The Test of Premorbid Functioning (TOP-F; Wechsler, 2011) gave estimated IQs 
ranging from 97 to 133.0 (M 113.91, SD 8.83). Twenty-four participants fell in the 
average range (90–110), 27 in the high average range (111–120), 11 in the superior 
range (121–129) and five in the very superior range (130–150).  
6.2.3 Fatigue 
The Fatigue Severity Score (FSS; Krupp et al., 1989) was employed to measure 
fatigue and the following categories, as outlined by Krupp et al. (1989), were applied: 
FSS < 4 (sub-clinical fatigue), 4 < FSS ≤ 5 (borderline fatigue) and FSS > 5 
(fatigued). 
Table 9. Classification and Scores on the Fatigue Severity Scale (FSS) for 90-minute 
Battery (N=67). 
 Number in Classification 
(%) 
Sub-clinical fatigue  
(FSS <4) 
43 
(64%) 
Borderline fatigue 
 (4 < FSS ≤5) 
22 
(33%) 
Fatigued  
(FSS > 5) 
2 
(3%) 
 
6.2.4 Anxiety and Depression  
Depression and anxiety were measured using the self-report Hospital Anxiety and 
Depression Scale (HADS; Zigmond & Snaith, 1983). The standard HADS 
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classification and cut-off scores for depression and anxiety were applied: normal (0–
7), mild (8–10), moderate (11–14) and severe (15–21). Table 10 shows the number of 
participants in each group, who self-reported on the Hospital Anxiety and Depression 
scale. 
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Table 10. Classification and Scores on the Hospital Anxiety and Depression Scale 
(HADS) for 90-minuite Battery (N=67). 
 Number in classification 
(%) 
Sub-clinical depression  
(Scores 0-7) 
65 
(97%) 
Mild depression  
(Scores 8–10) 
2 
(3%) 
Moderate depression 
(Scores 11–14) 
0 
(0%) 
Severe depression  
(Scores 15–21) 
0 
(0%) 
Sub-clinical anxiety  
(Scores 0–7) 
48 
(72%) 
Mild anxiety 
(Scores 8–10) 
14 
(21%) 
Moderate anxiety 
(Scores 11–14) 
5 
(7%) 
Severe anxiety 
(Scores 15–21) 
0 
(0%) 
6.3 Descriptives for Neuropsychological Measures 
Table 11 shows the means and SD for each of the neuropsychological measures 
within the 90-minute battery, which included the MoCA, MMSE, BICAMS and 
NINDS-VCI measures. As participants were administered the test in a 
counterbalanced order, t-tests were carried out to see if there had been significant 
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interference between the two verbal memory tests (CVLT-II and HVLT-R) and the 
two trails tests (MoCA and TMT-B), both t-tests showed no significant difference in 
scores between the two orders of test delivery on either the TMT-B (t (65)= -1.67, 
p>.05) or the HVLT-R delayed recall trial (t (65)=. 592, p>.05). 
 
Table 11. Means and Standard Deviations for all Neuropsychological Tests within the 
90-Minute battery (N=67). 
 
Mean (SD) 
MoCA 27.78 (1.56) 
MMSE 29.07 (1.08) 
BVMT-R Total Learning 23.63 (6.00) 
CVLT-II Total Learning 52.15 (9.16) 
SDMT 55.72 (8.55) 
WAIS-IV Digit Symbol Coding 72.28 (12.50) 
COWAT 45.61 (14.58) 
Semantic Fluency 22.51 (5.48) 
TMT A 23.40 (5.65) 
TMT B 44.18 (16.00) 
Rey Copy 35.57 (1.98) 
BNT 15.21 (1.59) 
HVLT-R Immediate Recall 25.15 (4.51) 
HVLT-R Delayed Recall 8.66 (2.57) 
RCFT Delayed Recall 20.69 (6.66) 
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The age of participants in this study was outside the age range for the normative UK 
data for the BICAMS battery. Mean scores on the BICAMS tests were compared with 
the full sample and an age-matched sample (Table 12). The means for the NINDS-
VCI battery were closer to the current UK normative data sample when participants 
who did not match the age range were removed from the analysis.  The lower means 
on BICAMS measures in this study shows how sensitive the BICAMS measures are 
to age effects, as the data shows that when participants are removed that are not 
within the age bracket of the normative data sample the means move closer together. 
However, the means in this study are still lower than the previous normative data 
collected in BICAMS. There is no known information on the frequency distribution of 
participants within the different age bands across the normative data populations. It 
may be that the current study has a high frequency of participants at the older end of 
this scale than the Orchard study, which is likely to be responsible for the current 
norms, even when matched for age still not being consistent with the Orchard study.  
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Table 12. Comparison of Means on BICAMS Across Different Healthy UK Control 
Samples. 
 Orchard et 
al. (2013) 
means 
90-minute battery 
full sample means 
90-minute battery 
age- matched 
sample means 
BVMT-R Total Learning 27.59 23.63 24.83 
CVLT-II Total Learning 55.87 52.15 54.29 
SDMT 62.16 55.72 56.88 
6.4 Number of Participants Falling Below Established Cut-Offs on the 
MoCA, MMSE and BICAMS  
Established cut-off scores for the MoCA, MMSE and BICAMS were applied 
(Orchard, 2013; Webb et al., 2014). Table 13 displays the frequency of participants 
falling within each range. Scores below 20 on the MoCA were classed as significant 
impairment, scores between 20 and 24 were mild cognitive impairment and scores of 
25 and above were no impairment.  In MMSE, scores below 23 were classed as 
significant impairment, scores between 24 and 26 were mild cognitive impairment 
and scores of 25 and above were no impairment. In BICAMS, the established 
consensus is 1.5SD below the mean on one or more tests (Dusankova et al., 2012; 
O’Connell et al., 2004; Orchard, 2013). Norms derived from a UK population were 
used for BICAMS (Orchard, 2013).  
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Table 13. Participants Falling Below the Established Cut-Off Scores on the MoCA, 
MMSE and BICAMS (N=67). 
 
No participants fell in the significantly impaired range on either the MMSE or 
the MoCA. BICAMS, and NINDS-VCI identified the two participants of the mildly 
impaired range on the MoCA.  
6.5 NINDS-VCI Battery 
Using similar procedures to that of earlier studies (Chen et al., 2015; Pendlebury et 
al., 2012; van Rooij et al., 2014), a z-score was calculated for each participant on each 
sub-test across the NINDS-VCI batteries. The z-score was derived for the mean and 
SD of the group on each neuropsychological test. TMT scores were *-1 as established 
by Chen et al. (2015). The modified Peterson criterion was then applied at the test 
level and at a domain level to compare the frequencies of those falling below the 
expected level. Table 14 shows the frequency of participants falling below the 
 MoCA MMSE BICAMS 
 Number in Classification 
(%) 
Significant Impairment  0 
(0%) 
0 
(0%) 
33 
(49%) 
Mild Impairment  2 
(3%) 
0 
(0%) 
 
No Impairment 65 
(97%) 
67 
(100%) 
34 
(51%) 
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expected level with different definitions of impairment used, as outlined in 
Pendlebury et al. (2013).   
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Table 14. Classification of Different Participants Using Different Impairment Criteria 
 Modified 
Peterson Criteria- 
single test definition 
Modified Peterson 
Criteria-multiple tests 
definition 
 1SD 1.5SD 2SD 1SD 1.5SD 2SD 
Total Impaired 51 
(76%) 
35 
(52%) 
16 
(24%) 
20 
(29%) 
13 
(19%) 
10 
(15%) 
Single Domain Impairment 18 23 13 12 11 3 
Amnestic 4 4 2 0 0 0 
Non-amnestic 16 19 11 12 11 9 
Multiple Domain Impairment 30 6 3 8 2 1 
Amnestic 18 0 0 6 0 0 
Non-amnestic 12 6 3 2 2 1 
 
 
Z-scores were also derived from the most suitable published norms available 
for each of the tests. These scores were compared with z-scores derived from the 
mean of the group. Participants were identified as falling below the expected level 
when they scored 1.5SD below the mean on one or more tests. Table shows the 
number of participants falling below the cut-off for each test.  
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Table 15. Frequency of Participants Scoring more than 1.5 SD Below the Mean 
Across all Neuropsychological Measure of the 90-Minute Battery from Published 
Norms and Means and Norms of the Current from the Current Group.  
 Participants 1.5SD below 
the mean on published 
norms 
Participants 1.5SD below 
the mean on current study 
norms 
WAIS-IV Digit Symbol Coding 0 3 
COWAT 6 4 
Sematic Fluency 10 7 
TMT A 7 6 
TMT B 3 4 
BNT 6 6 
Rey Copy 0 6 
HVLT-R immediate recall 25 6 
HVLT-R delayed recall 25 4 
RCFT- delayed recall  2 5 
 
Using published norms, a total of 45 participants were identified as falling 
below the expected level on one or more test. Using the group mean, 35 participants 
were identified as falling below the expected level in one or more test. A McNemar 
test was carried out to see if published norms identified a different proportion of 
participants to the group mean; the test was approaching significance p=. 052.  
When considering domains made up of multiple tests (executive function and 
memory), scores derived using the mean of the group showed that no participants 
scored below the expected level on a test of executive function or on a test of 
memory. This is compared with 1 and 22 participants, respectively, on published 
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norms. When z-scores were summed and averaged out across all tests, no participants 
fell less than 1.5 SD below the mean on either the published norms or the mean of 
group.  
6.6 Relationships to other Variables  
6.6.1 Correlations 
Bivariate correlations were carried out to evaluate the relationship between cognitive 
tests including NINDS-VCI z-score, BICAMS z-score, MoCA and MMSE to fatigue, 
depression and anxiety. These are displayed in Table 16.  
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Table 16. Summary of Correlations between Neuropsychological Measures and Clinical 
and Demographic Factors in the 90-Minute Battery (N=67). 
 
 
NINDS-
VCI  
BICAMS  MMSE MoCA FSS Depression Anxiety 
BICAMS  .358**       
MMSE .056 .398**      
MoCA .039 .217 408**     
FSS -.279* -.153 -.118 -.064    
Depression -.282 -.090 .127 .090 .537**   
Anxiety -.170 .153 .114 .016 .341** .582**  
Gender -.042 .060 .080 .140 -.011 -.081 .148 
*correlation is significant at the p<. 05,  
** correlation is significant at the p<. 01  
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Strong positive correlations were found between NINDS-VCI and BICAMS, 
BICAMS and MMSE, MoCA and MMSE, fatigue and HADS depression and HADS 
depression and anxiety scores (p<. 01). Weaker but still significant correlations were 
found between fatigue and NINDS-VCI and HADS depression and NINDS-VCI.  
Although fatigue was significantly negatively correlated with NINDS-VCI z-
score, when HADS anxiety and HADS depression were held constant, the correlation 
was no longer significant (p=. 211). There was a strong positive correlation between 
NINDS-VCI and BICAMS, but the correlation was not significant between MoCA 
and NINDS-VCI or MMSE and NINDS-VCI, which suggests that MoCA and MMSE 
do not capture the full normal range of scores that BICAMS and NINDS-VCI are 
capable of.  
Correlation with depression, anxiety and fatigue is not expected due to the low 
numbers of participants falling in the clinical range in the group.  
6.7 Development of Regression Based Norms  
6.7.1 NINDS-VCI 
A standard multiple regression was performed with total NINDS-VCI z-score as the 
dependent variable, and age2, years of education and estimated IQ as independent 
variables. The data were screened for violation of assumptions prior to analyses.  
An analysis of standard residuals was carried out, which showed that the data 
contained no outliers (Std. Residual Min = -2.532, Std. Residual Max = 1.942). 
Tests to see if the data met the assumption of collinearity indicated that 
multicollinearity was not a concern (Gender, Tolerance = 0.825, VIF = 1.212; Years 
of Education, Tolerance = .407, VIF = 2.459; Estimated IQ, Tolerance= .361, VIF = 
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2.767; Age2, Tolerance= .938, VIF =1.066). The data met the assumption of 
independent errors (Durbin-Watson value = .515). 
The histogram of standardised residuals indicated that the data contained 
approximately normally distributed errors, as did the normal P-P plot of standardised 
residuals, which showed points that were not completely on the line, but close. The 
scatterplot of standardised predicted values showed that the data met the assumptions 
of homogeneity of variance and linearity. 
The multiple regression was performed with total NINDS-VCI z-score as the 
dependent variable, and gender, age2, years of education and estimated IQ as 
independent variables. These variables accounted for a significant amount of the 
variance in total NINDS-VCI z-score (R2 = .18; F (4,62) = 4.59, p<. 01). 
The partial regression coefficients showed that years of education had a 
significant unique contribution to NINDS-VCI z-score (B = -.62, β = .442, t (62) = 
2.53, p<. 05). However, gender, estimated IQ and age2 were not independently 
associated with NINDS-VCI z-score (t (62) = 0.31, p =. 755), (t (62) = 0.16, p =. 87), 
(t (62) = 1.48, p =. 15), Therefore, the model showed a significant relationship to the 
DV, and this was carried by years of education.  
As years of education increases by 1SD (2.73), NINDS-VCI z-score will 
increase by.442. The SD for z-score is 0.38 so this constitutes a change of 0.17 
 (.442*.38). Therefore, for every 2.7 increase in years of education, an additional 0.17 
in NINDS-VCI z-score is found.  
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6.7.2 BICAMS 
A standard multiple regression was performed with total BICAMS z-score as the 
dependent variable, and age2, years of education and estimated IQ as independent 
variables. The data were screened for violation of assumptions prior to analyses.  
An analysis of standard residuals was carried out, which showed that the data 
contained no outliers (Std. Residual Min = -2.357, Std. Residual Max = 2.105). Tests 
to see if the data met the assumption of collinearity indicated that multicollinearity 
was not a concern (Years of Education, Tolerance = .428, VIF = 2.338; Estimated IQ, 
Tolerance= .427, VIF = 2.343; Age2, Tolerance= .938, VIF =1.066). The data met the 
assumption of independent errors (Durbin-Watson value = 2.014). The histogram of 
standardised residuals indicated that the data contained approximately normally 
distributed errors, as did the normal P-P plot of standardised residuals, which showed 
points that were not completely on the line, but close. The scatterplot of standardised 
predicted values showed that the data met the assumptions of homogeneity of 
variance and linearity. 
The multiple regression was performed with total BICAMS z-score as the 
dependent variable, and age2, years of education and estimated IQ as independent 
variables. These variables accounted for a significant amount of the variance in total 
BICAMS z-score (R2 = .27; F (3,63) = 6.138, p<. 01). 
The partial regression coefficients showed that age2 had a significant unique 
contribution to BICAMS z-score (B = -.000, β = -.446, t (63) = -4.076, p<. 001). 
However, estimated IQ and years of education were not independently associated with 
BICAMS z-score (t (63) = .961, p =. 340), (t (63) = -.066, p =. 95). Therefore, the 
model showed a significant relationship to the DV, and this was carried by age2. 
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As age2 increases by 1SD (1,368), BICAMS z-score decreases by .466. The 
SD for BICAMS z-score is 0.689, so this constitutes a change of 0.321. Therefore, for 
every 1367.56 increase on age2, a 0.321 decrease will be seen in BICAMS z-score.  
6.8 Sensitivity and Specificity of BICAMS, MoCA and MMSE  
To establish how accurate BICAMS is at detecting participants that fall below the 
expected level on the NINDS-VCI, accuracy, sensitivity and specificity were 
calculated. This was done by comparing the number of participants that NINDS-VCI 
highlighted as falling below the expected level and calculating how many of these 
were detected by BICAMS.  
Using the established international criteria for BICAMS (Orchard, 2013), the 
measure was 67% accurate with a sensitivity of 66% and a specificity of 69%, and a 
positive predictive value of 70% and negative predictive value of 65%. Figure 1 
shows the relationship between sensitivity and specificity in a ROC curve.  
A McNemar test was carried out to see if BICAMS identified a different 
proportion of participants to the NINDS-VCI; the results were non-significant p=. 
832.  
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Figure 1. ROC Curve Sensitivity and Specificity of BICAMS compared with NINDS-
VCI battery 
 
Further exploration of the sensitivity and specificity of the BICAMS was 
carried out at the 2SD cut-off for the BICAMS. This yielded a sensitivity of 35% and 
specificity of 89%. Using a 1 SD cut-off this yielded a sensitivity of 100% and a 
specificity of 35%. Optimal sensitivities and specificities using the MoCA and MMSE 
were investigated. MoCA accuracy =59%, optimal cut-off of >29, sensitivity =94%, 
specificity of 16%, >28, sensitivity =71%, specificity of 44% >27 sensitivity 37% and 
specificity = 69%. MMSE accuracy =68%, optimal cut-off of >29 sensitivity of 71%, 
specificity of 68%. As the MMSE is only scored out of 30 and the measure is most 
sensitive at detecting impairment at 30, the test has reached is ceiling, meaning even 
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those that score 100% on the test would be identified as in the ‘impaired’ range using 
this cut-off.  Therefore despite the highest levels of sensitivity and specificity we 
know that this cut off is not correctly identifying participants that fall in the impaired 
range. The BICAMS 1.5SD in one or more tests provides the best balance between 
sensitivity and specificity out of the three measures across the various cut-off points.  
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Table 17. Sensitivity and Specificity for BICAMs, MoCA and MMSE. 
  Sensitivity Specificity 
Test & cut off	 BICAMS 1SD cut off 100% 35% 
 BICAMS 1.5SD cut off 66% 69% 
BICAMS 2SD cut-off	 35% 89% 
MoCA >27 37% 69% 
MoCA >28 71% 44% 
MoCA >29 94% 16% 
 MMSE>29 71% 68% 
 
6.9 Summary of Results 
6.9.1 Hypothesis 1  
Published norms for the NINDS-VCI battery will provide significantly different cut- 
offs compared with the cut-offs established in a current UK sample. Hypothesis 1 was 
explored using McNemar chi-squared. Using published norms, a total of 45 
participants were identified as falling below the expected level in one or more tests. 
Using the group mean, 35 participants were identified as falling below the expected 
level in one or more tests. A McNemar test was carried out to see if published norms 
identified a different proportion of participants to the group mean; the test was 
approaching significance p=. 052.  
6.9.2 Hypothesis 2 
BICAMS will be more sensitive than the MoCA and MMSE at detecting participants 
that fall below the expected level on the NINDS-VCI battery. Optimal sensitivities 
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and specificities using the MoCA and MMSE were investigated. MoCA accuracy 
=59%, optimal cut-off of >29, sensitivity =94%, specificity of 16%, >28, sensitivity 
=71%, specificity of 44% >27 sensitivity 37% and specificity = 69%. MMSE 
accuracy =68%, optimal cut-off of >29 sensitivity of 71% specificity of 68%. This 
showed the ceiling effects of both tests. BICAMS was 67% accurate with a sensitivity 
of 66% and a specificity of 69, and a positive predictive value of 70% and negative 
predictive value of 65%.  
6.9.3 Hypothesis 3  
BICAMS will be able to identify correctly participants who fall below the expected 
level in the NINDS-VCI battery. McNemar test of proportions was used to assess how 
similar the proportion of participants identified by the BICAMS was to those 
identified by NINDS-VCI. There was a non-significant difference in the proportions 
identified between the tests (p=. 832).  
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7 Discussion 
It is known that people can suffer from cognitive impairments following TIA. Yet 
currently, ways of measuring impairment are inaccurate. While there is a gold 
standard battery to test cognition, there are no up-to date cohesive UK norms for the 
battery. Furthermore, current screening tools have been shown to have ceiling effects 
and to be insensitive in detecting mild cognitive impairments seen in a TIA profile.  
The current study aimed to explore whether a brief battery, which is used in MS and 
focuses on global deficits rather than focal deficits, could be an improvement on 
available tools. The sensitivity and specificity of BICAMS was compared with a gold 
standard measure of cognitive impairment in TIA (NINDS-VCI; Hachinski et al., 
2006). Furthermore, the study aimed to develop cohesive UK norms for the full 
NINDS-VCI battery to see if these would provide different outcomes to the current 
norm sources available. The study addressed the following questions: Will norms 
from current published sources provide different outcomes compared with a current 
healthy UK sample? Will BICAMS predict participants that fall below the expected 
level on a comparable level with the NINDS-VCI?  
 
7.1 Review of the Findings   
Hypothesis 1  
Published norms for the NINDS-VCI battery will provide significantly different cut- 
offs compared with the cut-off established from a current healthy UK sample. 
This hypothesis is partially supported. Numbers of participants classified as impaired 
using two different methods of scoring were compared. Norms recommended by 
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Hachinski et al. (2006), which were from a variety of sources, across different 
countries and different decades, were compared with a current UK healthy control 
sample. Rates of impairment classification were compared using chi-squared 
McNemar test of proportions. When comparing the number of participants identified 
as falling below the expected level of performance, the published norms identified 
more participants on the NINDS battery than the group mean method. Forty-five 
participants were identified as falling below the expected level on published norms, 
while 35 were identified as falling below the expected level on the group mean 
norming method.  
In 5 of the 10 sub-tests (COWAT, Semantic fluency, TMT A, HVLT-R 
immediate recall and HVLT-R delayed recall) more participants were identified as 
falling below the expected level on published norms. This was particularly evident in 
the HVLT-R tests, where 25 participants were identified by the published norms as 
falling below the expected levels on both immediate and delayed recall. The group 
mean identified more participants in four of the measures (WAIS Digit Symbol 
Coding, TMT-B, RCFT and RCFT delayed recall), although in much smaller 
numbers. A McNemar test was carried out to see if published norms identified a 
different proportion of participants to the group mean; the test was approaching 
significance p=. 052.  
 
Hypothesis 2  
BICAMS will be more sensitive than the MoCA and MMSE at detecting participants 
who fall below the expected level on the NINDS-VCI battery. This hypothesis was 
supported. BICAMS was more accurate, sensitive and specific than the MoCA. The 
MoCA demonstrated good sensitivity, but this was offset by the low specificity. 
  
 
110 
Although numbers were slightly higher for the MMSE, this was at a cut-off of 30 on 
the 30-point scale, meaning that the MMSE had reached its ceiling. However, 
BICAMS did not meet the recommended level of sensitivity and specificity for 
screening tests (Lincoln et al., 2003), although it should be noted that other widely 
used tools such as the MoCA and MMSE have also missed this recommendation. It is 
expected that screening tools will perform less well in non-clinical populations, as the 
spread of scores is likely to be smaller across healthy participants, and there will be 
much smaller and subtler deviations from the mean than what would be expected in a 
clinical sample, in which cognitive impairment is known to be prevalent. Other 
studies using the MoCA to detect mild cognitive impairments in a healthy population 
have shown higher rates of sensitivity and specificity than what was found in this 
study. However, the sample has a higher than average IQ, which may be partly 
responsible for this finding, as participants would have to score significantly less on a 
test before falling in the impaired range compared with those of a low average IQ. A 
recent meta- analysis found an optimum cut-off of 24/25, with a sensitivity of 80% 
and a specificity of 82% (Ciesielska et al., 2016), although participants were all over 
the age of 60. However, in studies using TIA populations, the MoCA’s high 
sensitivity has been associated with low specificity (Godefroy et al., 2011). This was 
in line with findings in this study. A recent meta-analysis of the MMSE in detecting 
mild cognitive impairments found similar results with an optimum cut-off point of 
27/28, yielding a sensitivity of 66% and specificity of 73%. In a study of the MMSE 
in a TIA population, Pendlebury et al. (2012) also found a ceiling effect for the 
MMSE and concluded that it is not a suitable tool for screening for single domain 
cognitive impairment. This is the general consensus in the literature (Burton & Tyson, 
2015a).  
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In studies where BICAMS has been compared with other neuropsychological 
batteries, similar rates of accuracy sensitivity and specificity have been found. For 
example, when being compared with the Minimal Assessment of Cognitive 
Functioning in Multiple Sclerosis (MACFIMS), sensitivity and specificity for 
experimental and control participants was found to be 85% and 83% respectively 
(Orchard et al., 2013), whilst in an MS only population sensitivity and specificity 
were 94% and 86% (Dusankova et al., 2012).  
This is the first study to compare directly the MMSE, MoCA and BICAMS in 
a healthy UK population. BICAMS shows promise as a tool that could be used to 
detect mild cognitive impairments in samples where deviations from expected 
performance levels are likely to be subtle.  BICAMS performed better than the 
MMSE and the MoCA in this particular sample. It is likely that using a clinical 
sample will increase the sensitivity and sensitivity of all of the measures, and that 
BICAMS may potentially perform at the desired level of above 80% sensitivity and 
specificity in a clinical population. As noted by the Cochrane reviews and other 
systematic reviews of the MMSE and the MoCA (Creavin et al., 2016; Burton & 
Tyson et al., 2015a) different cut-offs are optimal and different rates of sensitivity and 
specificity are found  depending on whether you are testing in a high or low 
prevalence setting. As the BICAMS has shown the most promising levels of 
sensitivity and specificity in a low prevalence setting we would cautiously predict that 
this would improve in a high prevalence setting such as a TIA clinic.  
  
Hypothesis 3 
BICAMS will be able to identify correctly participants who fall below the expected 
level on the NINDS-VCI. This hypothesis was supported. BICAMS was able to 
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identify correctly the majority of participants who fell below the expected level on the 
NINDS-VCI battery. These findings suggest that BICAMS could be a valid and 
sensitive screening tool for identifying cognitive impairment in a TIA population on a 
comparable level with the 60-minute NINDS-VCI battery. As BICAMS takes less 
than 15 minutes to administer, and could be delivered at routine healthcare 
appointments by a range of health professionals, it could increase our understanding 
of the rate of cognitive impairment after a TIA. Additionally, BICAMS allows us to 
assess and monitor those most at risk of poor prognostic outcomes following TIA.  
The results support findings in MS that BICAMS identifies cognitive 
impairment on a comparable level with other large batteries of tests (Dusankova et al., 
2012; Parmenter et al., 2010).  
7.2 Interpretation 
7.2.1 Current available published norm sources provide different rates of 
impairment compared with a current UK sample  
This finding is supported by current knowledge about normative data sets. The Flynn 
effect postulates that there will be changes in performance on neuropsychological 
tests over time and over generations. Thus, using normative data sets from over 10 
years ago will provide differing results compared with data collected from a current 
sample. It is widely recognised that the normative data used should match as closely 
as possible the current population of participants being studied. Key demographic 
factors have been identified that explain variation in performance such as age, 
education, IQ and socioeconomic status. The effects of using norms that do not match 
these key characteristics have not been thoroughly explored and documented for 
batteries where a diagnosis of cognitive impairment is being made, such as NINDS-
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VCI. This study goes some way to explaining the importance of accurate and cohesive 
norms and how they might influence findings, on an individual clinical and wider 
research level.  
A number of studies have compared older norms with revised norms, and 
scores have generally been found to increase over time; for example, the average 
number of words produced in the COWAT has increased by four from 1964 to 1996 
(Ruff et al., 1996). It is widely accepted that norms should not be considered stable 
over time as changing educational and cultural practices, including increased access to 
a wider range of media sources, influences tests. However, results in this study did not 
consistently show an increase in performance compared with averages from older 
tests, suggesting that the Flynn effect is unlikely to be responsible for the differing 
results. It is noteworthy that the biggest difference between the frequencies was 
observed in the HVLT-R with 25 participants being identified as falling below the 
expected level on immediate and delayed recall tests. Interestingly, verbal memory 
scores have been shown to be stable over time and not so susceptible to the Flynn 
effect (Baxendale, 2010).  
The data from the present study should be viewed as an initial step in the 
development of adequate cohesive normative data for the NINDS-VCI battery in a 
UK sample. However, the utility of this data from a healthy UK population also needs 
to be considered in light of the limitations outlined below before using them in current 
clinical and research practice.  
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7.2.2 BICAMS is more sensitive than the MMSE and the MoCA at detecting 
participants who fall below the expected level of scores on the NINDS-VCI in 
a healthy UK population   
As of yet, no studies have compared the BICAMS battery with the MoCA or MMSE, 
as BICAMS is a measure that has been validated only for use in MS. However, rates 
of sensitivity and specificity for the MoCA and MMSE are similar to what have been 
found in other studies of TIA. In particular, Godefroy et al. (2011) found that the 
sensitivity of the MOCA is associated with low specificity and inability to provide 
adequately across both criteria. In terms of the MMSE, our results confirmed the 
findings of  Pendlebury et al. (2012), that the MMSE has a ceiling effect and was not 
sensitive at picking up single domain impairments. These previous studies provide 
support for the current findings, which suggest that the MoCA and MMSE have 
significant flaws in detecting mild cognitive impairment. BICAMS may be a potential 
tool to address this. The Pearson’s correlation showed that BICAMS was highly 
correlated with NINDS-VCI battery; this is likely to be because both batteries can 
assess scores over a wide range of performance levels, rather than the MoCA and the 
MMSE, which reach their ceiling in detecting subtle deviations from expected levels.   
BICAMS measures scores over a wider spread of ability, meaning that it is 
able to detect subtle changes in performance levels, across key tests that require 
distributed processes. This appears to give a more sensitive reflection of impairment 
rather than measuring a range of focal deficits at a low level. A recent study looking 
at stroke participants supports this, and shows that participants can score full marks 
within a MoCA specific domain and still be impaired on corresponding 
neuropsychological assessments that assess the full domain (Chan, Altendorff, Healy, 
Werring, & Cipolotti, 2017). This is supported by other studies looking at severe 
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cognitive impairments, where poor correlations with the MoCA sub-domains and 
their corresponding standard cognitive test have been found (Coleman, Coleman, 
MacKinley, Pasternak, & Finger, 2017). This suggests that testing participants with a 
low level, simplified version of a test is a compromise rather than using a test that can 
assess their full ability. An alternative approach that BICAMS utilises is detecting 
impairment across global skills rather than testing a range of domains at a low level, 
which is shown to give an inaccurate account of performance and cognition.   
This interpretation is evidently limited to a healthy UK population, and we 
cannot necessarily infer how BICAMS would perform in detecting cognitive 
impairments in TIA participants. However, it shows potential as an area that warrants 
further research and investigation. Screening tools such as the MoCA and MMSE are 
often used to measure the usefulness of treatment interventions in reducing 
impairments and the risk of further cardiovascular disease (Pettigrew et al., 2000). 
Studies have not been able to demonstrate any reversible or stabilising effects on 
cognition, using medication. This may be due to the insensitivity of screening tools 
utilised. If it is not viable to use a full battery such as the 60-minute NINDS-VCI, 
ways to improve on the sensitivity and specificity of screening tools are imperative to 
ensure that we are accurately identifying and discarding the right treatments for VCI. 
A more sensitive measure may provide different outcomes.  
7.2.3 Years of education explains a significant amount of the variance in test scores 
in the NINDS-VCI battery and scores should be adjusted accordingly  
A multiple regression analysis showed that years of education explained a significant 
amount of the variance in NINDS-VCI scores. This suggests that scores should be 
adjusted to account for different educational backgrounds to ensure test scores 
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accurately account for this. The cognitive reserve hypothesis (Stern, 2012) supports 
the finding that years of education significantly predicts NINDS-VCI performance; 
participants of higher educational attainment are likely to perform better on cognitive 
tests. Therefore, should they experience a decline in their cognition they would have 
further to descend before being identified as falling below the mean. For this reason, 
other researchers have noted the need to improve the sensitivity and specificity of 
tests for individuals who are above average intelligence (Drebing, Van Gorp, Stuck, 
Mitrushina, & Beck, 1994; Rentz et al., 2004). In accounting for differences in 
educational attainment, those with high educational achievements will still be 
detected even when their scores fall within the broader average range. This will allow 
participants to be identified at an early stage of impairment, rather than waiting for 
their scores to decline even more significantly before being detected by the battery.  
The next step would be to look at each of the individual tests within the 
NINDS-VCI and to run multiple regression analyses on each test. It is likely that 
some tests in the battery will be influenced more heavily by demographic factors than 
others, and by summing all measures some of this individual variation across tests 
will be lost. For example, in other studies, estimated IQ has been found to be a 
significant predictor of TMT-B score, but not TMT-A (Testa et al., 2009).  
7.2.4 Age2 explains a significant amount of the variance in test scores in BICAMS 
and scores should be adjusted accordingly  
A multiple regression analysis showed that age2 accounts for a significant amount of 
the variance in BICAMS scores. Thus, when using this test on clinical participants, 
their scores should be adjusted accordingly to account for the effect of demographic 
information. Age is a factor that has long been known to affect performance on 
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neuropsychological tests and in particular speed timed tests (Ruff & Parker, 1993), of 
which BICAMS contains two (SDMT, and BVMT-R). Most normative data sets 
provide age-banded norms to account for this. The use of the regression-based model 
to determine this is of benefit because the participant’s scores do not dramatically 
change form one age band to the next, but all scores are adjusted on a sliding scale 
dependent on age.   
It is likely that age will affect tests in BICAMS to varying degrees; the next 
step would be to examine how each test is impacted by demographic variables, and to 
provide regression-based norms on an individual test. 
  
7.3 Strengths and Limitations of the Study    
7.3.1 Sampling 
Information on gender, age2, depression, anxiety, fatigue, years and education and 
estimated IQ were collated in the study. This is a relative strength as these factors 
were all analysed. In particular, rates of depression, anxiety and a fatigue are likely to 
be higher in a TIA population (Broomfield et al., 2014; Moran et al., 2013; Yu et al., 
2015). Being able to compare the prevalence of anxiety, depression and fatigue in 
healthy controls with TIA participants will not only help with further stratification of 
the data, but also aid the understanding of how these clinical factors may change in 
people who have experienced a TIA, as well as the impact on cognitive testing in a 
clinical group.  
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7.3.1.1 Age  
The average age of participants was 43.86 years. The mean average age across other 
studies of TIA have ranged from 61 to 73 years (Giles & Rothwell, 2007). A younger 
sample was chosen in this study to limit the influence of concomitant cognitive 
disorders, such as the impact of older age on cognition and other possible disease, 
which might impact cognition in later life. Furthermore, people who experience a 
cognitive impairment after TIA earlier in life are likely to experience a greater impact 
on their working life, productivity and family life. They will also have a longer, more 
chronic VCI pathway. Therefore, having data available for a younger population is 
useful in being able to assess the cognitive impairment in this group. This is in 
keeping with other research studies in the area that have looked specifically at 
cognitive impairment after TIA in people under the age of 65 (van Rooij et al., 2014) 
and other studies that have shown that TIA in younger people has the largest effects 
on quality of life (Franzén-Dahlin & Laska, 2012).  Future studies should consider 
how to widen the age range within the sample, whilst limiting the influence of age-
related concomitant cognitive disorders.  
7.3.1.2 Gender  
Although there is a higher ratio of women to men included in both samples, there 
were no significant correlations between gender and neuropsychological tests. 
However, depending on cultural practices, particularly in older participants, there may 
be significant differences in years of education and gender. As years of education is a 
significant predictor of scores on the NINDS-VCI further studies should ensure years 
of education is equally split between male and female participants.  
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7.3.1.3 Estimated IQ 
Similarly, measures of pre-morbid IQ and years of education allowed for improved 
understanding of the sample. However, this highlighted that the sample was above 
average in estimated IQ. The spread of scores within the IQ range was also quite 
limited as all participants were in the average range or above, which may in part 
explain why estimated IQ was not a significant predictor of BICAMS or NINDS-VCI 
z-scores. However years of education was more varied within the sample and was 
shown to be a significant predictor of NINDS-VCI scores. However, researchers have 
noted the importance of designing sensitive and specific measures for higher 
cognitively functioning adults, particularly those aged below 69 as their risk of 
neurological disease is gradually increasing, while work and family responsibilities 
remain high for many (Drebing et al., 1994).   
The TOP-F was used as an estimated measure of pre-morbid IQ. This is 
usually used with participants who have experienced some level of cognitive decline. 
Although the TOP-F is highly correlated with WAIS performance, using a full 
measure of IQ would have been more appropriate in this study. Replicating the study 
with a full measure of IQ and with participants who span the full range of IQ would 
be a helpful addition to developing cohesive and current norms for comparison on 
NINDS-VCI and BICAMS.   
7.3.1.4 Sampling methods 
It may be that people are more likely to take part in cognition research if they believe 
that they have cognitive difficulties. Many people who took part in the study also 
revealed some history of neurological disturbance in their own family. It may be 
possible that some participants had undetected neurological conditions. Similarly, 
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other cardiovascular risk factors such as hypertension and diabetes are known to 
affect cognition (Gorelick et al., 2011). These were not controlled for in the current 
study. The use of neuroimaging techniques and risk stratification information for 
participants would be useful in overcoming difficulties, but this was beyond the scope 
of the current study.  
7.3.1.5 Samples size  
Sixty-seven participants were recruited to the main study. This is a relatively small 
sample, although within the recommended sample for the multiple regression analyses 
(Testa et al., 2009), but well below the recommended level using traditional norming 
methods, where it is recommended that 50–75 participants per variable are required. 
Bridges and Holler (2007) suggested that that small sample sizes may lead to 
overpathologising results. It is interesting to note that within the regression analyses, 
there were a number of significant correlations (age and IQ), but they did not explain 
an individual significant proportion of the variance. One possible explanation for this 
finding is that the study was underpowered. It may be that with a larger sample these 
correlations could have contributed to a significant amount of the variance 
individually.  
 
7.3.2 Study Design 
7.3.2.1 Test selection 
A general strength of the study is that the neuropsychological tests were given in a 
counterbalanced order to prevent order effects. However, during the administration it 
was noted that those who received the CVLT–II first, and then received the HVLT-R 
later, experienced some interference when they completed the delayed recall trial of 
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the HVLT-R. Nevertheless, when looking at the findings there was no significant 
difference on the HVLT-R and CVLT-II between odd and even numbered 
participants. Similarly, it should be noted that a trail making test was repeated in the 
MoCA and as part of the TMT individual sub-test. This meant that the task was not 
novel for some participants the first time they approached the task. However, there 
were no significant differences between odd and even numbered participants scores 
on the TMT task, showing that previous exposure of the MoCA trail or the TMT task 
did not interfere with the performance on either test.  
7.3.2.2 Assessment conditions  
Participants were tested in their homes or at their place of work across both groups. 
This is different to the usual testing environment, which is usually within a clinical 
setting such as a hospital or clinic room. Although attempts were made to minimise 
distractions, there were notably some distractors, which may have influenced 
performance. TIA participants are likely to be tested in a clinical environment with 
fewer distractions, which may result in improved performance compared with the 
control group. However, they are likely to have also experienced a stressful medical 
event that impacted their ability to concentrate and perform on neuropsychological 
tests. Furthermore, the time of day participants were tested varied across the group, 
depending on their availability to complete testing. Level of fatigue at different times 
of day may influence scores within the group, which may not have been detected in 
the FSS. 
7.3.2.3 Test Administration 
Instructions for delivering the MoCA are provided by Nasreddine et al. (2005). A 
discrepancy in the instructions delivered to participants and the standardised 
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instructions were discovered post-testing. Both sets of instructions are included in the 
appendices (Appendix 17 and 18) for comparison. The fact that the instructions differ 
from the standardised instruction may have made it more difficult to achieve a higher 
score on the MoCA. However, using available conversion tables which compare how 
MoCA scores should compare with MMSE scores, we can see that the scores on the 
MoCA are within the 95% confidence intervals that we would expect based on the 
MMSE scores (Bergeron et al., 2017). This means that the MoCA scores were not 
significantly influenced by the deviation from the standardised instructions and 
highlights the robustness of the MoCA for clinical use.  
The pilot group and the control group found different rates of falling below the 
expected level, with 31% of the pilot group falling within the mild cognitive 
impairment range on the MoCA. This is compared with 3% of the NINDS-VCI group. 
There was also a disparity across the MMSE and BICAMS measures in both groups, 
with more participants in the pilot group scoring below the expected level than in the 
NINDS-VCI battery. Other studies have also found similarly high rates of scores 
below the cut-offs with participants from a healthy population when using the MoCA 
(Binder, Iverson, & Brooks, 2009; Palmer, Boone, Lesser, & Wohl, 1998; Rossetti, 
Lacritz, Cullum, & Weiner, 2011). One possible explanation for this discrepancy is 
differences in the test administrators across the pilot group and main study. A trainee 
clinical psychologist, who was trained in delivering neuropsychological tests, 
conducted the NINDS-VCI battery, whereas postgraduate students, from another 
science discipline and with little training, administered the pilot group tests. This 
would have implications for the use of such screening tools being implemented and 
used by non-clinical health care professionals. It highlights the importance of 
experience and training in delivery. As these tools are being developed for delivery by 
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non-specialist healthcare professionals, it will be important that training is carried out 
and test administrators are examined on their standardisation and adherence to formal 
testing procedures across clinical settings and research settings.  However, cognitive 
screening tools have been successfully delivered by a range of healthcare 
professionals, with sufficient training and supervision (Chodosh et al., 2008). This is 
an area of research that may warrant further investigation before the implication of 
screening tools to be used by non-clinical health care professionals with TIA patients.  
A further explanation for the discrepancy in findings between NINDS-VCI 
and the pilot group, may be linked to the latter’s demographic factors; age was shown 
to have a significant negative correlation with scores in the pilot group. However, age 
data were not available for 33 participants, which may have meant that part of the 
sample was drawn from a particularly older group of participants, who were more 
likely to have experienced age-related cognitive decline. Furthermore, years of 
education in the NINDS-VCI group was shown to explain a significant amount of the 
variance in the regression model for the NINDS-VCI battery. As such data were not 
available for the pilot group, we cannot be sure if they are from the same population 
as the NINDS-VCI group, because they have above average IQ. Neither group was 
given the educational point for less than 12 years of education. In this way, the effect 
of years of education could be explored in the analyses. However, there were very few 
participants within the NINDS-VCI group who would have gained an extra point. As 
we did not have information on years of education for the pilot group, it may be that 
more participants warranted an extra point added for lower years of education. This 
could then have brought scores more in line with a normal healthy UK population.  
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7.3.3 Statistical Methods 
7.3.3.1 Level of impairment classification  
In this study, participants were classified as falling below the expected level on the 
NINDS-VCI battery when they scored 1.5SD below the mean on one or more tests. 
Thirty-five participants fell below the expected level in one or more tests. The criteria 
included a higher proportion of participants than the more conservative 2SD cut-off in 
one or more tests, but a lower proportion of participants than the criteria to fall below 
the expected level in more than one test within a domain, or multiple domain 
impairment. However, even more participants would have been identified if the 
criteria of falling 1SD below the expected level in one or more tests was used. Other 
authors have used other cut-off criteria; for example, Chen et al. (2015) averaged 
scores across the domain and used a cut-off of 1.5SD below the mean to establish 
impairment. Using this method, no participants were identified as falling below the 
expected level (1.5SD on average from the domain) for executive function or memory 
and when averaging all of the sub-domain scores, no participants scored less than 
1.5SD below the mean as an average across all tests. It was harder for participants to 
‘fail’ the executive functioning domain as this was averaged across five tests, whereas 
memory consisted of three tests and language and visuospatial skills one test each. 
This clearly shows the criteria used impacts on the rate of impairment found and in 
which domains, and, in turn, influences the sensitivity and specificity of any screening 
tool being tested. This is a limitation that has been discussed in other studies (Liepelt-
Scarfone et al., 2011; Pendlebury, Mariz, et al., 2013), where a fourfold increase can 
be observed in rates of impairment depending on the definition that is used.  It would 
be a misrepresentation to say that 49% of the sample were impaired, as participants 
  
 
125 
were from the general population and not reporting any cognitive deficits. This 
highlights the importance of a thorough clinical interview and accounting for self and 
family reports of cognition alongside cognitive screening and or testing before 
making diagnosis of cognitive impairment. Different cut-offs and different ways of 
calculating impairment should be explored both with BICAMS and the NINDS-VCI, 
such as averaging scores, which may be more specific and lead to less false positive 
than the current cut-off criteria, other statistical methods such as the Monte Carlo 
simulation methods had been explored too (Binder et al., 2009; Palmer et al., 1998). 
As the number of tests administered increases it is more likely that participants will 
score below the expected level in one or more tests. The development of base rates 
which calculate the likelihood of a participant having such discrepant scores could 
help to ascertain if the scatter of scores is within the normal range.  
Future studies with a clinical sample of TIA participants should further 
explore which criteria is most sensitive to detecting cognitive impairment, whilst 
limiting the rate of false positives. As VCI is known to be present in the executive 
functioning domain  it would be of interest to see how many TIA participants fall 
below the expected level when all five tests of executive functioning, within the 
NINDS-VCI are averaged. The cut-offs chosen will have clear implications for the 
accuracy, sensitivity and specificity of a screening measure, such as BICAMS. In 
clinical practice, it will have implications for those who are identified and receive 
further treatment and rehabilitation.  
7.3.3.2 BICAMS norms 
Norms for the BICAMS were based on a healthy UK sample of 68 participants with a 
mean age of 44 (SD 10 years), range 27–60, of which 37 were female and 31 were 
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male, with an average of 16 years of education (SD 2.8), and average estimated IQ of 
111 (SD 8.8). The normative data provided higher means on every measure used 
within BICAMS. Whilst this did quite closely match the group in the current study, 
when those outside the age range of the norms data were removed, the means of 
scores on the BICAMS moved closer towards the means of the normative data sample 
used (See Table 12). This corroborates the findings of age being an important 
independent predictor of BICAMS score and demonstrates the importance of ensuring 
the normative data are reflective of the individual being assessed, both in research and 
clinical practice.  
7.4 Clinical Implications of the Study   
Deficits in cognition have implications for people’s everyday functioning after 
experiencing a TIA or mild stroke. Activities of daily living, quality of life and 
relationships are all affected by cognitive decline. This will particularly affect young 
adults who have a longer and more chronic duration of VCI. The cognitive difficulties 
associated with TIA and mild stroke are likely to have impact on employment, 
finances and wellbeing.  
It is important that people who have had a TIA and mild stroke have access to 
appropriate cognitive testing to help them understand the difficulties and access 
appropriate services and support. BICAMS shows promise as a short assessment 
battery to assess cognition. It could be a useful instrument in understanding more 
about the prevalence of cognitive impairment after a TIA, and provide further 
evidence of the need for cognitive assessment and rehabilitation to be part of the 
NICE guidelines for this client group. Furthermore, the battery could prove useful in 
identifying those most at risk of having further cerebrovascular events, and help 
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clinicians target treatment in time-limited appointments within TIA clinics, which are 
conducted by various non-psychology healthcare professionals. It could be a useful 
tool for baseline measures and follow-up to track the course of disease progression.  
BICAMS could be used to identify individuals who would benefit from further 
in-depth cognitive testing. Having reliable, consistent and specific information on the 
rates of cognitive impairment and how this impacts long-term health outcomes will 
raise awareness of the importance of cognitive testing in this population. It is hoped 
that this initiates a change in the NICE guidelines to recommend cognitive testing 
after a TIA as standard practice.  
7.5 Directions for Further Research   
This is a small-scale investigation into the utility of BICAMS as a cognitive measure, 
which may be useful in detecting mild impairments in people who have experienced a 
TIA, and into the development of UK norms for the 60-minute NINDS-VCI battery.  
A clear goal would be to use a larger sample of healthy controls to develop 
normative data for the NINDS-VCI performance in a UK population across a wider 
age, estimated IQ and education level. Providing up to date and cohesive norms 
would help build a firm basis for the development of further research into VCI and 
TIA, knowing that clinical data are comparable with an appropriate normative and 
representative sample. National databases already exist for the collation of data and 
findings; it is important that what we are contributing is an accurate measure of 
cognitive impairment in TIA populations in the UK. The development of cohesive 
and relevant norms alongside clear guidance for classifying impairment will further 
aid longitudinal studies to understand the long-term impact of cognitive impairment 
and the true predictive value of cognitive testing in the acute stage after a TIA. 
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Longitudinal studies that use the same scales and criteria for impairment are important 
to compare precisely and effectively and draw firm conclusions from the findings.  
Additionally, future research should test BICAMS with TIA participants to see 
if it is sensitive at detecting those who fall below the mean on the NINDS-VCI, as it 
has been in healthy control participants. This may lead to further exploration of 
whether tests could be substituted or supplemented within BICAMS to be more 
sensitive to VCI.   
Large-scale collaborative studies that employ more sophisticated sampling 
techniques should be used. The use of brain imaging data to support cognitive testing 
findings would also be invaluable. 
7.6 Conclusion 
No studies have provided a normative UK sample for the NINDS-VCI battery. This 
study investigated whether a UK sample is likely to differ in performance on the 
NINDS-VCI battery compared with the current variety of norms available. It was 
found that UK participants did differ in their performance, and thus it was highlighted 
the importance of using relevant and cohesive norms when testing cognitive 
impairment in clinical samples.  
Furthermore, this study investigated the sensitivity and specificity of BICAMS 
to detect participants whose scores fall below the expected level on the NINDS-VCI 
battery. It showed promise as a suitable brief test to detect cognitive impairment in 
TIA.  
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Appendix 1- Ethics Details 
 
 
  
 
 
Research question summary:
Does the Brief International Cognitive  Assessment for MS (BICAMS) constitute a better cognitive assessment for TIA than the currently
used assessments (MOCA and MMSE)?
 
The most widely used assessments of cognition in TIA clinics are the Montreal Cognitive Assessment (MOCA) and Mini Mental State
Examination (MMSE). The MOCA is designed to detect mild cognitive impairment, including Alzheimer's disease. The MMSE is a screening
test for dementia. Both are constructed to test a range of focal deficits, at a low level ("a set of low hurdles"). They have a marked false
negative rate. BICAMS calibrates information processing speed and memory function over the whole range of mental abilities and is
therefore a more precise measure of distributed cognitive processes, hypothesised to be a more accurate assessment of the distributed
cerebral vascular pathology sustained by TIA patients and hence their cognitive impairment. In order to validate BICAMS for TIA, we will
also be including the "gold standard" NINDS battery. In multiple sclerosis, the 15 minute BICAMS has been shown to have equivalent
sensitivity to cognitive impairment to the "gold standard" MACFIMS.
 
Research method summary:
This application is asking for permission to collect normal control data on the battery. Once IRAS ethics permission has come through, I will
re-apply for permission to assess NHS patients.
 
A battery of cognitive tests, taking less than 30 minutes in total, will be administered to healthy control participants. This will comprise the
MOCA, the MMSE and BICAMS. There are brief cognitive assessments which have been used in research with thousands of patients
across the world.
 
A proportion of participants will also complete the longer, "gold standard" NINDS battery, which takes another 30 minutes.
 
NINDS battery -(Hachinski et al., 2006).  Testing frontal/executive, attentional, language, visuospatial, and memory domains. It takes
approximately 50 to 60 minutes to administer. This compromises:
a. Trail Test (Parts A and B) (Reitan, 1955; (Ivnik, Malec, Smith, Tangalos, & Petersen, 1996) 
b. Boston Naming Test (30-item version)(Franzen, Haut, Rankin, & Keefover, 1995)  
c. Rey-Osterrieth complex Figure copy (Fastenau, Denburg, & Hufford, 1999).   
d. Hopkins Verbal Learning Test- Revised (Brandt, 1991; Benedict, Schretlen, Groninger, & Brandt, 1998)
e. Letter (Controlled Oral Word Association Test) (Benton, Hamsher, & Sivan, 1994)
f. Category (animals) fluency (Issacs & Kennie, 1973)
 
All participants will also complete the
Hospital Anxiety and Depression Scale (HADS), a measure has been validated in a stroke cohort (Spurgeon et al., 2015; Burton and Tyson,
2015);
and the Fatigue Severity Scale (Krupp, LaRocca, Muir-Nash, & Steinberg, 1989), the psychometric properties of this scale have been
validated using a stroke cohort (Lerdal & Kottorp, 2011).
 
 
Ethics Review Details
You have chosen to self certify your project.
Name: Langdon, D
Email: D.Langdon@rhul.ac.uk
Title of research project or grant: Brief International Cognitive Assessment for TIA (BICAT)
Project type: Royal Holloway staff research project/grant
Department: Psychology
Funding Body Category: No external funder
Funding Body:
Start date: 01/04/2016
End date: 31/03/2019
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Risks to participants
 
Does your research involve any of the below?
Children (under the age of 16),
No
 
Participants with cognitive or physical impairment that may render them unable to give informed consent,
No
 
Participants who may be vulnerable for personal, emotional, psychological or other reasons,
No
 
Participants who may become vulnerable as a result of the conduct of the study (e.g. because it raises sensitive issues) or as a result of
what is revealed in the study (e.g. criminal behaviour, or behaviour which is culturally or socially questionable),
No
 
Participants in unequal power relations (e.g. groups that you teach or work with, in which participants may feel coerced or unable to
withdraw),
No
 
Participants who are likely to suffer negative consequences if identified (e.g. professional censure, exposure to stigma or abuse, damage to
professional or social standing),
No
 
Details,
 
 
Design and Data
 
Does your study include any of the following?
 
Will it be necessary for participants to take part in the study without their knowledge and/or informed consent at the time?,
No
 
Is there a risk that participants may be or become identifiable?,
No
 
Is pain or discomfort likely to result from the study?,
No
 
Could the study induce psychological stress or anxiety, or cause harm or negative consequences beyond the risks encountered in normal
life?,
No
 
Does this research require approval from the NHS?,
No
 
If so what is the NHS Approval number,
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Are drugs, placebos or other substances to be administered to the study participants, or will the study involve invasive, intrusive or
potentially harmful procedures of any kind?,
No
 
Will human tissue including blood, saliva, urine, faeces, sperm or eggs be collected or used in the project?,
No
 
Will the research involve the use of administrative or secure data that requires permission from the appropriate authorities before use?,
No
 
Will financial inducements (other than reasonable expenses and compensation for time) be offered to participants?,
No
 
Is there a risk that any of the material, data, or outcomes to be used in this study has been derived from ethically-unsound procedures?,
No
 
Details,
 
 
Risks to the Environment / Society
 
Will the conduct of the research pose risks to the environment, site, society, or artifacts?,
No
 
Will the research be undertaken on private or government property without permission?,
No
 
Will geological or sedimentological samples be removed without permission?, 
No
 
Will cultural or archaeological artifacts be removed without permission?,
No
 
Details,
 
 
Risks to Researchers/Institution
 
Does your research present any of the following risks to researchers or to the institution?
 
Is there a possibility that the researcher could be placed in a vulnerable situation either emotionally or physically (e.g. by being alone with
vulnerable, or potentially aggressive participants, by entering an unsafe environment, or by working in countries in which there is unrest)?,
No
 
Is the topic of the research sensitive or controversial such that the researcher could be ethically or legally compromised (e.g. as a result of
disclosures made during the research)?,
No
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Will the research involve the investigation or observation of illegal practices, or the participation in illegal practices?,
No
 
Could any aspects of the research mean that the University has failed in its duty to care for researchers, participants, or the environment /
society?,
No
 
Is there any reputational risk concerning the source of your funding?,
No
 
Is there any other ethical issue that may arise during the conduct of this study that could bring the institution into disrepute?,
No
 
Details,
 
 
Declaration
By submitting this form, I declare that the questions above have been answered truthfully and to the best of my knowledge and belief, and
that I take full responsibility for these responses. I undertake to observe ethical principles throughout the research project and to report any
changes that affect the ethics of the project to the University Research Ethics Committee for review.
 
Certificate produced for user ID, uhjt092
 
Date: 21/03/2016 15:03
Signed by: Langdon, D
Digital Signature: Dawn Langdon
Certificate dated: 3/21/2016 3:45:38 PM
Files uploaded:
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Appendix 2- Information Leaflet 
 
 
  
Research	in	Memory	and	Concentra2on	
a3er	Minor	stroke	or	TIA	
A3er	a	minor	stroke	people	experience	diﬃcul2es	with	memory	and	
concentra2on.	We	need	to	collect	informa2on	about	healthy	people’s	
memory	and	concentra2on	to	work	out	what	has	been	aﬀected	in	TIA	
pa2ents.	
	
If	you	chose	to	take	part	you	will	be	asked	to	complete	various	tests,	which	
measure	your	aFen2on,	memory,	language,	visuo-spa2al	and	problem	
solving	skills.		Some	use	spoken	language	whilst	others	pencil	and	paper.		
You	may	ﬁnd	some	easy	and	others	more	challenging	but	most	people	ﬁnd	
them	enjoyable.			
	
Par2cipa2on	will	take	about	1	hour	and	can	usually	be	completed	in	one	
session	with	breaks	if	you	need	them.		
	
Please	contact	me	if	you	would	like	to	take	part	or	for	any	further	
informa2on:		
Danielle.lambert.2011@live.rhul.ac.uk	
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Information	about	the	Research	
	
Study	Title:	Cognition	in	TIA	
	
We	would	like	to	invite	you	to	take	part	in	our	research	study.		Before	you	decide	we	would	like	you	to	
understand	why	the	research	is	being	done	and	what	it	would	involve.		Someone	will	go	through	the	
information	sheet	with	you,	discuss	the	information	and	answer	any	questions	you	have.		
Please	feel	free	to	talk	to	others	about	the	study	if	you	wish.		
	
Part	1	tells	you	the	background/purpose	of	the	study	and	what	will	happen	to	you	if	you	take	part.		
Part	2	gives	you	more	detailed	information	about	the	conduct	of	the	study.		
	
Ask	us	if	anything	is	not	clear.	
	
Important	Contacts	
	
Site	where	the	research	is	taking	place:	
Some	participant’s	homes	or		
Royal	Holloway,	University	of	London	
•	 Dept.	of	Clinical	Psychology,	Bowyer	Building,	Royal	Holloway	University	of	London,	Egham,	Surrey,	
TW20	0EX,	 Telephone:	01784	443851	
•	
Questions	about	the	research	can	be	directed	to:	
The	Chief	Investigator:	Professor	Dawn	Langdon	
• Dept.	of	Clinical	Psychology,	Royal	Holloway	University	of	London,	Egham,	Surrey,	TW20	0EX	
• Tel:	01784	443	851	
• Email:	d.langdon@rhul.ac.uk	
	
	
Complaints	procedure:	
If	you	have	a	concern	about	any	aspect	of	this	study,	you	should	ask	to	speak	to	the	Chief	Investigator	
mentioned	above	who	will	do	her	best	to	answer	your	questions	(01784	443	851).			
	
If	you	remain	unhappy	and	wish	to	complain	formally,	you	can	do	this	by	contacting	
	
Professor	Dawn	Langdon,		
Department	of	Psychology,	Royal	Holloway	University	of	London,	Egham,	Surrey,	TW20	0EX	
Email:	d.langdon@rhul.ac.uk		
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Part	1	
	
Background	to	the	project	
People	who	have	experienced	transient	ischaemic	attacks	(TIA’s)	or	minor	strokes,	may	have	subsequent	
difficulties	with	memory	and	concentration	(“cognition”).	We	need	to	collect	information	about	healthy	
people’s	memory	and	concentration	to	work	out	what	has	been	affected	in	TIA	patients.	
	
Purpose	of	the	research	
The	current	study	aims	to	validate	a	measure	(BICAMS)	which	could	be	used	in	less	specialist	centres	by	a	
variety	of	health	care	professionals	as	a	brief	cognitive	assessment	tool.	
	
Who	can	take	part?	
You	are	eligible	to	take	part	if	you	are	between	18	and	60	years	old	and	your	first	language	is	English.		We	
will	also	not	be	able	to	include	you	if	you	are	currently	abusing	drugs	or	alcohol	or	if	you	have	a	significant	
psychiatric	condition.		You	should	also	not	have	any	medical	condition	which	could	affect	your	cognitive	
skills.		If	you	are	unsure	that	any	of	these	apply	to	you,	please	discuss	it	with	the	chief	investigator.	
	
Do	I	have	to	take	part?	
Your	participation	is	completely	voluntary.	We	would	like	you	to	take	part	because	we	believe	you	can	make	
a	significant	contribution	to	the	research	and	healthcare	of	people	with	MS.			
	
How	do	I	take	part?	
If	you	agree	to	take	part,	someone	will	go	through	the	information	sheet	with	you	and	you	will	be	asked	to	
sign	a	consent	form.		Please	bear	in	mind	that	you	are	free	to	withdraw	at	any	time,	without	giving	a	reason.		
What	will	I	have	to	do	if	I	take	part?	
You	will	be	asked	to	complete	various	tests,	which	measure	your	attention,	memory,	language,	visuo-spatial	
and	problem	solving	skills.		Some	use	spoken	language	whilst	others	pencil	and	paper.		You	may	find	some	
easy	and	others	more	challenging	but	most	people	find	them	enjoyable.		
	
Where	will	I	have	to	go	and	for	how	long?	
The	researcher	may	see	participants	at	Royal	Holloway,	University	of	London,	or	in	community	settings.	
	
Participation	will	take	about	2	hours	and	can	usually	be	completed	in	one	session	with	breaks	if	you	need	
them.	
 
Part	2	
	
What	are	the	potential	benefits	of	taking	part?	
Whilst	there	may	be	no	personal	benefits	to	participating,	the	information	you	give	could	greatly	contribute	
to	improvements	in	the	availability	of	cognitive	testing	for	people	with	TIA.	
	
Are	there	possible	disadvantages	or	risks	involved	in	taking	part?	
It	is	possible	that	the	tests	may	cause	you	to	feel	fatigued.		If	this	happens	you	can	ask	to	take	a	break	or	we	
can	arrange	another	time	to	finish	testing.	
	
Will	my	participation	be	kept	confidential?	
We	will	follow	ethical	and	legal	practice	to	ensure	that	all	information	you	provide	to	us,	and	the	results	
from	your	tests	will	be	kept	strictly	confidential.		All	data	will	be	coded	anonymously	and	stored	securely.	
	
The	overall	results	of	the	study	will	be	made	public	in	a	completely	anonymous	form	ensuring	that	no	
participants	can	be	identified.	
	
What	will	happen	to	my	results	after	the	study?		
All	your	information	will	be	stored	anonymously.		Analysis	of	the	information	obtained	will	be	completed	on	
a	computer	by	the	chief	investigator	based	at	Royal	Holloway,	University	of	London.		
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The	broad	findings	of	the	study	will	be	published	in	a	scientific	paper	or	peer	reviewed	journal	and	used	to	
compile	the	chief	investigator’s	Doctoral	Thesis.		They	may	also	be	distributed	through	voluntary	
organisations	such	as	the	MS	Society	and	presented	at	appropriate	scientific	conferences.		
	
If	you	would	like	a	summary	of	the	study’s	findings	please	indicate	this	on	the	consent	form.			
	
What	will	happen	if	I	want	to	withdraw	from	the	study?	
You	can	decide	you	no	longer	wish	to	take	part	at	any	point.		Results	from	testing	you	have	completed	will	
be	destroyed.	This	will	not	affect	the	standard	of	care	you	receive	or	your	legal	rights.	
	
Should	you	give	consent	and	later	lose	capacity	to	do	so	we	will	include	your	data	in	the	study	unless	you	
indicate	otherwise	on	the	consent	form.	
	
Who	is	organising	the	research?		
The	study	is	being	organised	and	undertaken	by	post	graduate	students	and	is	sponsored	by	Royal	Holloway	
University	of	London.	
	
Ethics	permission	for	this	study	has	been	granted	by	Royal	Holloway,	University	of	London.		
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Appendix 4- Fatigue Severity Scale Questionnaire 
This appendix has been removed due to copyright.  
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Appendix 5- Hospital Anxiety and Depression Scale 
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Appendix 6- Trail Making Test 
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Appendix 7- The Boston Naming Test 
This appendix has been removed due to copyright.  
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Appendix 8- The Rey Ostreith Complex Figure Test 
 
This appendix has been removed due to copyright.  
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Appendix 9- The Hopkins Verbal Learning Test 
This appendix has been removed due to copyright.  
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Appendix 10- Wechsler Coding Test  
This appendix has been removed due to copyright.  
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Appendix 11- Symbol Digits Modalities Test (SDMT) 
This Appendix has been removed due to copy right. 
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Appendix 12- California Verbal Learning Test (CVLT) 
This Appendix has been removed due to copy right.   
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Appendix 13- The Brief Visuospatial Memory Test-Revised 
(BVMT-R) 
This Appendix has been removed due to copy right. 
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Appendix 14- Montreal Cognitive Assessment (MoCA)  
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Appendix 15- The Mini-Mental State Examination- MMSE  
This Appendix has been removed due to copyright. 
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Appendix 16-Test of Premorbid Functioning (TOP-F) 
This Appendix has been removed due to copy right. 
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Appendix 14- MoCA Instructions used in the study  
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Appendix 18- Standardised MoCA instructions.  
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Montreal Cognitive Assessment  
(MoCA)  
 
Administration and Scoring Instructions  
 
The Montreal Cognitive Assessment (MoCA) was designed as a rapid screening instrument for mild 
cognitive dysfunction. It assesses different cognitive domains: attention and concentration, executive 
functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and 
orientation. Time to administer the MoCA is approximately 10 minutes. The total possible score is 30 
points; a score of 26 or above is considered normal.  
 
1. Alternating Trail Making:  
 
Administration: The examiner instructs the subject: "Please draw a line, going from a number 
to a  letter in ascending order. Begin here [point to (1)] and draw a line from 1 then to A 
then to 2 and so  on. End here [point to (E)]."  
 
Scoring: Allocate one point if the subject successfully draws the following pattern:  
 1 −A- 2- B- 3- C- 4- D- 5- E, without drawing any lines that cross. Any error that is not 
immediately  self-corrected earns a score of 0.  
 
 
2. Visuoconstructional Skills (Cube):  
 
Administration: The examiner gives the following instructions, pointing to the cube: “Copy this 
drawing as accurately as you can, in the space below”.  
 
Scoring: One point is allocated for a correctly executed drawing.  
• Drawing must be three-dimensional  
• All lines are drawn  
• No line is added  
• Lines are relatively parallel and their length is similar (rectangular prisms are accepted)  
 
A point is not assigned if any of the above-criteria are not met.  
 
 
3. Visuoconstructional Skills (Clock):  
 
Administration: Indicate the right third of the space and give the following instructions: “Draw 
a clock. Put in all the numbers and set the time to 10 past 11”.  
 
Scoring: One point is allocated for each of the following three criteria:  
•  Contour (1 pt.): the clock face must be a circle with only minor distortion acceptable (e.g., 
slight imperfection on closing the circle);  
• Numbers (1 pt.): all clock numbers must be present with no additional numbers; numbers 
must be in the correct order and placed in the approximate quadrants on the clock face; Roman 
numerals are acceptable; numbers can be placed outside the circle contour;  
•  Hands (1 pt.): there must be two hands jointly indicating the correct time; the hour hand must 
be clearly shorter than the minute hand; hands must be centred within the clock face with their 
junction close to the clock centre.  
 
A point is not assigned for a given element if any of the above-criteria are not met.  
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Serial 7s: Administration: The examiner gives the following instruction: “Now, I will ask you to 
count by subtracting seven from 100, and then, keep subtracting seven from your answer until I 
tell you to stop.” Give this instruction twice if necessary.  
 
Scoring: This item is scored out of 3 points. Give no (0) points for no correct subtractions, 1 
point for one correction subtraction, 2 points for two-to-three correct subtractions, and 3 points 
if the participant successfully makes four or five correct subtractions. Count each correct 
subtraction of 7 beginning at 100. Each subtraction is evaluated independently; that is, if the 
participant responds with an incorrect number but continues to correctly subtract 7 from it, give 
a point for each correct subtraction. For example, a participant may respond “92 – 85 – 78 – 71 
– 64” where the “92” is incorrect, but all subsequent numbers are subtracted correctly. This is 
one error and the item would be given a score of 3.  
 
 
7. Sentence repetition:  
 
Administration: The examiner gives the following instructions: “I am going to read you a 
sentence. Repeat it after me, exactly as I say it [pause]: I only know that John is the one to 
help today.” Following the response, say: “Now I am going to read you another sentence. 
Repeat it after me, exactly as I say it [pause]: The cat always hid under the couch when dogs 
were in the room.”  
 
Scoring: Allocate 1 point for each sentence correctly repeated. Repetition must be exact. Be 
alert for errors that are omissions (e.g., omitting "only", "always") and substitutions/additions 
(e.g., "John is the one who helped today;" substituting "hides" for "hid", altering plurals, etc.).  
 
 
8. Verbal fluency:  
 
Administration: The examiner gives the following instruction: “Tell me as many words as you 
can think of that begin with a certain letter of the alphabet that I will tell you in a moment. You 
can say any kind of word you want, except for proper nouns (like Bob or Boston), numbers, or 
words that begin with the same sound but have a different suffix, for example, love, lover, 
loving. I will tell you to stop after one minute. Are you ready? [Pause] Now, tell me as many 
words as you can think of that begin with the letter F. [time for 60 sec]. Stop.”  
 
Scoring: Allocate one point if the subject generates 11 words or more in 60 sec. Record the 
subject’s response in the bottom or side margins.  
 
 
9. Abstraction:  
 
Administration: The examiner asks the subject to explain what each pair of words has in 
common, starting with the example: “Tell me how an orange and a banana are alike”. If the 
subject answers in a concrete manner, then say only one additional time: “Tell me another way 
in which those items are alike”. If the subject does not give the appropriate response (fruit), 
say, “Yes, and they are also both fruit.” Do not give any additional instructions or clarification.  
After the practice trial, say: “Now, tell me how a train and a bicycle are alike”. Following the 
response, administer the second trial, saying: “Now tell me how a ruler and a watch are alike”. 
Do not give any additional instructions or prompts.  
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Scoring: Only the last two item pairs are scored. Give 1 point to each item pair correctly 
answered. The following responses are acceptable:  
Train-bicycle = means of transportation, means of travelling, you take trips in both;  
Ruler-watch = measuring instruments, used to measure.  
The following responses are not acceptable: Train-bicycle = they have wheels; Ruler-
watch = they have numbers.  
 
10. Delayed recall:  
 
Administration: The examiner gives the following instruction: “I read some words to you 
earlier, which I asked you to remember. Tell me as many of those words as you can 
remember.” Make a check mark ( √ ) for each of the words correctly recalled spontaneously 
without any cues, in the allocated space.  
 
Scoring: Allocate 1 point for each word recalled freely without any cues.  
 
Optional:  
Following the delayed free recall trial, prompt the subject with the semantic category cue 
provided below for any word not recalled. Make a check mark ( √ ) in the allocated space if the 
subject remembered the word with the help of a category or multiple-choice cue. Prompt all 
non-recalled words in this manner. If the subject does not recall the word after the category cue, 
give him/her a multiple choice trial, using the following example instruction, “Which of the 
following words do you think it was, NOSE, FACE, or HAND?”  
Use the following category and/or multiple-choice cues for each word, when appropriate:  
 
FACE:  category cue: part of the body   multiple choice: nose, face, hand  
VELVET:  category cue: type of fabric   multiple choice: denim, cotton, velvet  
CHURCH:  category cue: type of building   multiple choice: church, school, hospital  
DAISY:  category cue: type of flower   multiple choice: rose, daisy, tulip  
RED:  category cue: a colour    multiple choice: red, blue, green  
 
Scoring: No points are allocated for words recalled with a cue. A cue is used for clinical 
information purposes only and can give the test interpreter additional information about the 
type of memory disorder. For memory deficits due to retrieval failures, performance can be 
improved with a cue. For memory deficits due to encoding failures, performance does not 
improve with a cue.  
 
11. Orientation:  
 
Administration: The examiner gives the following instructions: “Tell me the date today”. If the 
subject does not give a complete answer, then prompt accordingly by saying: “Tell me the 
[year, month, exact date, and day of the week].” Then say: “Now, tell me the name of this 
place, and which city it is in.”  
 
Scoring: Give one point for each item correctly answered. The subject must tell the exact date 
and the exact place (name of hospital, clinic, office). No points are allocated if subject makes 
an error of one day for the day and date.  
 
TOTAL SCORE: Sum all subscores listed on the right-hand side. Add one point for an 
individual who has 12 years or fewer of formal education, for a possible maximum of 30 points. 
A final total score of 26 and above is considered normal.  
 
